Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Офтальмология / Английские материалы / Principles and Practice of Clinical Electrophsyiology of Vision_Heckenlively, Bernard Arden_2006.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
33.81 Mб
Скачать

XV ANIMAL TESTING

This page intentionally left blank

81 Evaluating Retinal Function in the

Mouse Retina with the

Electroretinogram

.

The electroretinogram

As described in previous chapters, the electroretinogram (ERG) recorded from the corneal surface of the eye represents the massed response of the retina to light stimulation. The ERG is easily recorded from the mouse eye with minor modifications of the general methodologies that have been employed for humans for many years. The basic methodology for recording the ERG in the mouse has been described in detail elsewhere.34 The solid curve shown in figure 81.1 is an example of an ERG recording from a normal C57BL/6J mouse in response to a bright flash of light. The major components of the response are the a-wave, which is the first negative corneal potential, and the b-wave, which is the first positive corneal potential. ERGs to bright flashes presented in the dark also contain a high-frequency oscillatory component on the ascending limb of the b-wave, collectively called the oscillatory potentials (OPs). An example record of dark-adapted OPs obtained from a normal C57BL/6J mouse are shown in the lower left panel of figure 81.2. After the onset of steady illumination, the relatively fast a- and b- waves are followed by a slower positive-going c-wave (not shown in figure 81.1). Other components of the ERG not shown in figure 81.1 will be described below.

The cellular origins of ERG components

Under dark-adapted conditions, the leading edge of the a- wave is generally associated with rod photoreceptor activity.13,14,39 The b-wave is associated with the combined activity of depolarizing bipolar cells and bipolar cell–dependent K+ currents affecting Muller cells.18,30,32,42,51,58 The cellular origin of the OPs is not completely understood, although they are likely generated by amacrine cells and other inner retinal cells interacting with bipolar and ganglion cells.19,25,35,54,55 The c-wave of the ERG is a corneal positive potential recorded across the retinal pigment epithelium (RPE) and results from an increase in the RPE’s transepithelial potential.16 Because of the technical difficulties in recording the c-

wave, it has not found general use in the mouse, although a recent studies have demonstrated its potential usefulness as an analytic tool (see, e.g., Wu et al.56).

Contributions from amacrine and ganglion cells have also been identified in the scotopic threshold response (STR), which is a negative-going potential in the dark-adapted ERG that is present at threshold and with dim illumination.49 The STR has been recorded from human, primate, cat, and rat retinas, but so far, there are no publications demonstrating such recordings from the mouse (for rats, see Bush, Hawks, and Sieving,5 and Sugawara, Sieving, and Bush53).

Rodand cone-mediated ERGs

The mouse retina is dominated by rod photoreceptors with a peak sensitivity at 510 nm, corresponding to the spectral absorption characteristics of rhodopsin. Estimates of cone percentages in the mouse retina range from 1% to 10%, with most studies suggesting that approximately 3% of photoreceptors are cones.7,29,47 Morphologically, the cones of the mouse are indistinguishable from those of higher mammals.7 Molecular biological, histological, and flicker electroretinographic results have established that mice have two cone photopigments: one peaking near 350 nm (UV-cone pigment) and a second near 510 nm (midwave [M]-cone pigment).23,24,53 ERG techniques for isolating the action spectra and absolute sensitivities of the UV-cone and M- cone driven signals have been described.27 The properties of the cone driven light-adapted murine ERG have also been described,9,37 as have regional variations in cone function.6

ERG responses obtained to dim flashes of light after a period of dark adaptation are generally presumed to derive from rod photoreceptors. Care must be exercised to ensure sufficient time to completely dark-adapt rods, as some recent studies suggest differences in the time necessary to achieve a fully dark-adapted state. Overnight dark adaptation is usually sufficient for most standard inbred strains. ERG responses obtained after a period of light adaptation are generally presumed to be driven by cone photoreceptors.

:

899

oscillatory potentials (OPs)

b-wave

flash onset

peak-to-peak

a-wave

50 V

25 ms

F 81.1 Representative ERG response to a bright flash obtained from a normal adult C57BL6 mouse. (See text for details.)

When the light stimulus does not emit a significant amount of ultraviolet (UV) light, then the response to a light flash on a rod-saturating background is mediated primarily by the middle-wavelength-sensitive cone (M-cone). Light sources with broad emission spectra are required to isolate the UVsensitive cone. As with humans, the period of light adaptation suppresses the contribution from rods, thereby yielding a cone-dominated signal. Further, presenting stimuli at a temporal frequency above the critical fusion frequency (CFF) for rods is an additional method that is sometimes used to isolate a cone response. In a recent study in our own laboratory, the rod CFF was found to be 6–7 Hz (Nusinowitz, unpublished data).

A note of caution should be added to the above discussion. Responses under a variety of conditions that theoretically suppress the contribution from rods do not always derive from cone photoreceptors. ERG studies in a mouse model of Leber’s congenital amaurosis (LCA) caused by mutations in the gene encoding RPE65, a protein vital for regeneration of the visual pigment rhodopsin in the retinal pigment epithelium, produce a severe retinal phenotype in which residual function is usually attributed to cones in the light-adapted state. However, in an elegant study, the rod system was shown to be the source of vision in the RPE65deficient mouse, not cones, even under conditions that would normally completely suppress rods.45

Representative rodand cone-mediated ERGs from a normal C57BL/6J mouse are shown in the upper left and right panels of figure 81.2. Each trace shows the response to a different light intensity, which is varied in 0.3 log unit steps. The b-wave of the rod-mediated response increases in amplitude, and implicit times (time from flash onset to peak of b-wave) are shortened with increasing intensity (compare

the heavy solid curves). The b-wave amplitude versus intensity (I-R) series for the rod-mediated responses is summarized in the inset. Note that the b-wave amplitude saturates at the highest intensities. The I-R series can be fitted with a Naka-Rushton function to obtain the maximum saturated b-wave amplitude, Vmax; the semisaturation intensity, k; a measure of sensitivity; and the ERG threshold intensity. In contrast, cone-mediated responses collected under the conditions employed in our laboratory increase in amplitude but have relatively constant timing (compare the heavy solid curve in the upper right panel of figure 81.2). The I-R series for the cone responses are shown in the inset. At flash intensities beyond those used to generate the data shown, cone amplitudes also saturate, thereby allowing fits with the NakaRushton equation as for rod-mediated function.

Basic ERG recording technique

In laboratories where mouse ERGs are currently recorded, different recording techniques (e.g., electrodes), methods of stimulating the eye (e.g., Ganzfeld versus Maxwellian view), and experimental protocols are employed (see, e.g., Green et al.,15 Marti et al.,28 Peachey et al.,38 Ruether et al.,44 Shaaban et al.,46 and Smith and Hamasaki50). In principle, the techniques for recording the ERG from the mouse are virtually identical to those used in human studies. The major components of a typical ERG system are (1) a light source for stimulating the retina, (2) electrodes for recording the signal generated by the retina in response to light, (3) a signal amplification system, and (4) a data acquisition system to accumulate, condition, and display data. Most commercial systems have integrated all of these elements into a single unit. A comparison of physiological recording systems that can be used for mouse ERGs are described in chapter 19. In addition, a comprehensive description of ERG recording methodologies can be found in Nusinowitz et al.34

Factors affecting the ERG

There are many variables that affect the ERG, and standard and consistent techniques are imperative to reduce the sometimes wide variability seen in mouse ERG recordings. Improper technique strongly affects the ERG and greatly reduces the reliability and reproducibility of data. Increased variability within ERG responses decreases the test’s ability to detect differences between strains and within strains over time, particularly when these changes are subtle. Variables that can affect the ERG include the improper use of anesthetics, variations in body temperature, insufficient dilation, inadequate light or dark adaptation, and prolonged testing, all of which can lead to a decrease in response amplitude. Location of the electrode on the eye can alter the amplitude of a signal by up to 30–40%, and a decrease in mouse body

900

F 81.2 Rod (upper left panel) and cone (upper right panel) ERGs obtained from a normal C57BL6/J mouse. Each trace displays the response to increasing light intensities. Upper left inset, Peak-to- peak amplitude versus retinal illuminance fitted with a Naka-Rushton function to obtain the maximum saturated b-wave amplitude, Vmax, the semisaturation intensity, k, and the rod ERG threshold. Right inset, Cone b-wave amplitude versus intensity series fitted with a

temperature by just a few degrees is associated with a virtually nondetectable ERG. Repeated flashing, commonly used in signal averaging, reduces rod-mediated (but not conemediated) ERG response amplitudes by about 20% at high flash intensities unless flash presentation rate is slowed to allow sufficient recovery of rod function. The consequences on the ERG of inappropriate control of extraneous variables are described in Nusinowitz et al.34 and Ridder et al.41

Specialized ERG recording techniques

By setting specific stimulus conditions, the ERG can be used to index the functional status of a wide range of cell types and can provide information to better understand the site and mechanisms of disease action (see figure 81.4 later in the chapter).

linear regression to derive the cone ERG threshold intensity. Lower left, A single ERG recording filtered to illustrate the major oscillatory potentials. Lower right, Representative a-wave ERG recordings to a range of flash intensities for a normal mouse. The smooth dotted curves are the fit of a rod model (see text for details) from which estimates for RmP3, the maximum saturated photoreceptor response, and S, a sensitivity parameter, were derived. (See text for details.)

Long-duration stimuli have been reported suitable for dissecting the contribution of ON and OFF bipolar cells to the photopic ERG.48 For example, while the photopic b-wave is largely generated by cones and the depolarizing ON bipolar cells, the activity of the hyperpolarizing OFF bipolar cells can limit the size and shape of the b-wave. These different components can be evaluated separately with long-duration flashes that produce distinct waveform components at flash onset and offset. While standard ERG recordings are in response to brief flashes less than 10 ms in duration, the separation of ON and OFF components requires longer flashes that are typically 100–200 ms in duration. Clinical application of the long-duration stimulus to such disease entities as congenital stationary night blindness31 and paraneoplastic night blindness1 have been reported in humans.

:

901

a-Wave analyses: Studies of activation and inactivation steps of phototransduction

Photoreceptor structure and function can be studied by analyzing the leading edge of the ERG (called the a-wave) obtained to bright flashes.3,4,8,20,21 Prior research suggests that current quantitative rod models have the potential to discriminate structural from functional abnormalities as the underlying mechanism of disease action in retinal disease (see, e.g., Birch et al.2 and Hood and Birch22). These techniques have been used extensively in the mouse.10–12,26,33,36,38,40,43,57 However, this type of a-wave analysis requires stimulus intensities that are substantially higher than are available with conventional photic stimulators. Intensities that clearly saturate the a-wave of the ERG are required. High-output xenon arc lamps and photographic flash heads can be adapted for this purpose and can provide intensities 2.0–4.0log units higher than a standard flash.

An example of recordings to high-intensity flashes is shown in figure 81.2 (lower right panel) for a normal mouse. Dark-adapted ERGs were recorded to blue light flashes up to 3.1 log scot td s in 0.3 log unit steps. The first 30 ms of each of the responses is shown in the figure. Note that the amplitude of the a-wave is fairly stable at the highest intensities and that the time to the peak of the a-wave is shortened. The leading edge of the rod a-waves was fitted with a model of the activation phase of phototransduction.22 The fit of the model to the raw data is indicated by the dotted lines. Generated by the model are three parameters: S, RmP 3, and td. S is a sensitivity parameter that scales flash energy. In general, any factor that decreases quantal catch or affects the gain at one or more of the steps involved in phototransduction will result in a reduction in the estimate of S. RmP3 is propor-

tional to the magnitude of the circulating current in the rod outer-segment membrane at the time of flash presentation.4,8,20,21 A number of factors can affect this circulating current, including the ionic driving force within the cell (perhaps determined by the number of mitochondria), the electrical resistance and/or leakage of the photoreceptor layer, immaturities in membrane proteins that mediate the permeability of the outer limiting membrane, and/or the density of light-sensitive channels distributed along the rod outer segment (ROS). The parameter td is a brief delay before response onset.

The kinetics of recovery to bright flashes can be studied using a two-flash technique. Recovery cannot be measured directly in the ERG because of the intrusion of postreceptor components. However, recovery can be inferred from the amplitude of the a-wave response to a second saturating test flash. An example of rod a-wave responses to a test flash at varying interstimulus intervals (ISIs) following a bright conditioning flash is shown in figure 81.3 (left panel). The test flash response in isolation is shown as the tracing labeled baseline. The other tracings show the a-wave response to the same test flash but with different ISIs ranging from 50 to 250 ms. Note that the a-wave amplitude increases as the ISI is elongated, consistent with rod functional recovery. Repetition of this two-flash paradigm with variations of the interval (ISIs) between the first and subsequent saturating flash allows determination of the recovery time course for a given conditioning flash intensity and Tc, the critical delay before the onset of recovery. Examples of normalized a- wave amplitudes to a test flash at varying ISIs are shown in figure 81.3 (right panel) for a dim and a bright conditioning flash (first flash). Note the faster recovery to baseline for the dim conditioning flash. We have previously reported that

100

 

 

 

 

1.2

 

Td = .91 secs

 

 

 

 

 

)

 

 

 

50

 

 

 

(max

1.0

dim first flash

tau = 23.93

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

amplitude–50

50 ms

 

 

(t)/Response

0.8

 

 

 

 

 

 

 

 

bright first flash

 

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.6

 

 

 

 

 

 

 

 

Response

0.4

 

 

Td = 4.95 secs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

–100

 

 

 

 

 

 

 

tau = 140.24

 

 

250 ms

 

 

0.2

 

 

 

 

 

 

 

 

 

 

 

 

–150

 

baseline

 

 

0.0

 

 

 

 

 

 

 

 

 

 

 

 

0

10

20

30

 

0

50

100

150

200

 

time (ms)

 

 

 

 

time (sec)

 

 

 

 

 

 

 

 

F

81.3 Kinetics

of recovery to

bright saturating

flashes.

Left, Representative a-wave responses to a probe

flash at

varying times

following a bright

test flash. Right,

Normalized a-wave amplitudes to

a probe flash at varying

ISIs for a dim and a bright

test flash. (See text for

details.)

 

902

patients with retinitis pigmentosa and a Pro23His rhodopsin mutation not only had a decrease in the gain of activation but also had significantly slower recovery times to bright saturating flashes.2 More recently, we have used this technique to demonstrate a slowed photoreceptor recovery following an intense bleach in albino mice with a MET450 variant in RPE65.34 A modification of this technique can be used to obtain the full time course of the rod response in vivo to test flashes of subsaturating intensity.17

Interstrain differences in ERG parameters for normal inbred mouse strains

Standard inbred mouse strains provide a stable genetic background for the study of specific genes and their role in retinal degeneration. However, little has been published about retinal function across (normal) inbred strains without known retinopathy when tested with a standardized protocol and at the same age. In our laboratory, we characterized retinal function in normal inbred mouse strains using the ERG to provide normative data for a broad range of physiological parameters. These data are intended to provide a standard against which transgenic and knock-out mice on similar backgrounds can be evaluated.

G T P We recorded intensityresponse series to evaluate both rodand cone-mediated function (examples are shown in the upper panels of figure 81.2). Rod-mediated ERGs were recorded to brief flashes of short-wavelength (W47A; 8max = 470 nm) light presented to the dark-adapted eye. Cone-mediated responses were obtained with white flashes on a rod-saturating background. The Naka-Rushton parameters, Vmax, the saturated b-wave amplitude, k, retinal sensitivity, and rod ERG threshold were derived from the intensity-response series. Oscillatory potentials (OP) were recorded in the dark-adapted eye using bright flashes of white light. Amplitude and timing were determined for each of the first four major OPs, as shown in figure 81.2. Flash intensity was extended to record rodmediated photoresponses in the mouse as shown in the lower left panel of figure 81.2. Rod photoresponse parameters were derived from the fit of a rod model to the leading edge of the a-wave. From these photoresponses, we derived RmP3, the maximum saturated photoreceptor amplitude, and S, photoreceptor sensitivity, as previously described.33 Finally, cone-mediated maximum amplitude and ERG threshold were also determined.

S S ERGs were recorded from 11 normal inbred mouse strains (mean age 13 ± 3 weeks). The strains investigated were C57BL/6J, NZB/BINJ, A/J, C57BL/6Jc2J, BALB/cJ, NZW/LacJ, AKR, CBA/CaJ, DBA/2J, DBA/1j, and LP/J. All mice were obtained from the Jackson Laboratory.

R -M R The results for the NakaRushton analysis of the b-wave intensity-response series are shown in figures 81.4 and 81.5. Across all strains, Vmax, the saturated b-wave amplitude, ranged from 194 mV (± 77) to 374 (± 99) mV. The albino strains on average produced the highest-amplitude signals, with marginally significant differences across strains (Vmax for albino strains = 314 ± 90 mV, P = 0.061). The two black strains on average produced amplitudes that were lower than those of the albino strains but that were not significantly different from those of either the albino or agouti strains (Vmax for black strains = 280 ± 63 mV, P = 0.395). However, the agouti, or mixed coat, strains produced saturated amplitudes with wide variation across the strains (Vmax for brown/agouti strains = 278 [± 99] mV, P = 0.0002). Multiple comparisons suggested that the largest difference among the agouti strains occurred for the CBA and LP/J strains (P < 0.01).

The retinal sensitivity parameter, k, derived from the Naka-Rushton fit, also varied across strains, ranging from 0.0015 ± 0.008 to 0.032 ± 0.033 scotopic td s (lower panel of figure 81.4). Again, the albino strains produced the lowest values of k (highest sensitivity), with significant variation across strains (k for albino strains = 0.0062 ± 0.008), P < 0.0001), the agouti strains producing the lowest sensitivity (k for brown/agouti strains = 0.0195 ± 0.009, P = 0.32) and the black strains producing intermediate sensitivity (k for black strains = 0.0166 ± 0.008, P = 0.10). In general, the parameters Vmax and k were loosely correlated, with the higher saturated amplitudes also producing higher sensitivity values. Finally, ERG threshold intensity and k were highly correlated, as shown in figure 81.5.

O P An analysis of the oscillatory potentials is shown in figure 81.6. The upper panel shows the summed amplitudes (OPsum) of the four dominant components of the ERG waveform. The lower panel shows the individual amplitudes for each of the four components. OPsum amplitudes were significantly different across the three coat colors. OPsum amplitude was 56.5 ± 35.0, 35.5 ± 13.0, and 79.8 + 28.0 mV for the black, albino, and brown/agouti strains, respectively (P < 0.0001). Surprisingly, the albino strains produced the lowest OP amplitudes despite generating the highest Vmax amplitudes. Statistically significant differences within the black and agouti strains were present, but no such differences were observed across the albino strains. Finally, the timing of OP peak components was not significantly different across all strains (P > 0.05).

a-W P As previously described,33 the leading edge of the rod ERG was fitted with a rod model to derive parameters of photoreceptor structure and function. The parameters, RmP3, the photoreceptor saturated amplitude, and S, photoreceptor sensitivity, were calculated. The results are shown in figure 81.7. An analysis of a-wave revealed that

:

903

Naka-Rushton Parameters

Vmax

 

500

 

 

 

 

 

 

 

 

 

 

black

 

albino

 

 

 

brown/agouti

 

V)

400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(

 

 

 

 

 

 

 

 

 

Amplitude

300

 

 

 

 

 

 

 

 

200

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

max

 

 

 

 

 

 

 

 

V

100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0

 

 

 

 

 

 

 

 

 

NZB

C57BL

AJ

BALB/cJ NZW/LJ

AKR

C2J

CBA

DBA/1J DBA/2J

LP/J

 

 

 

 

 

k

 

 

 

 

 

0.04

 

 

 

 

 

 

 

 

 

black

 

albino

 

 

 

brown/agouti

 

td-s)

0.03

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

k (scotopic

0.02

 

 

 

 

 

 

 

 

 

0.01

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.00

 

 

 

 

 

 

 

 

 

 

NZB

C57BL

AJ

BALB/cJ NZW/LJ

AKR

C2J

CBA

DBA/1J

DBA/2J

LP/J

Mouse Strain

F 81.4 Naka-Rushton parameters derived from rod-mediated intensity versus b-wave amplitude response series. Upper panel, Mean

(± 1 standard error) saturated b-wave amplitudes across strains. Lower panel, Mean (± 1 standard error) retinal sensitivity across strains.

k vs threshold

–2

 

 

 

 

 

 

–3

 

 

 

 

 

 

–4

 

 

 

 

 

 

lthresholdog

 

 

 

black

 

 

–5

 

 

 

 

 

 

 

 

albino

 

 

 

 

 

 

 

 

 

 

 

 

brown/agouti

 

 

–6

 

 

 

 

 

 

0.00

0.01

0.02

0.03

0.04

0.05

0.06

log k

F 81.5 Correlation between rod ERG threshold and sensitivity (k) across normal mouse strains.

904

Oscillatory Potentials (OPs)

 

150

 

 

 

 

 

 

 

 

( V)

black

 

albino

 

 

 

brown/agouti

 

 

 

 

 

 

 

 

 

 

amplitude

100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

summed

50

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0

 

 

 

 

 

 

 

 

 

NZB

C57BL

AJ

BALB/cJ NZW/LJ

AKR

C2J

CBA

DBA/1J DBA/2J

LP/J

Mouse Strain

 

50

 

 

 

 

 

 

 

 

( V)

black

 

albino

 

 

 

brown/agouti

 

40

 

 

 

 

 

 

 

 

amplitude

 

 

 

 

 

 

 

 

30

 

 

 

 

 

 

 

 

20

 

 

 

 

 

 

 

 

-OP4

 

 

 

 

 

 

 

 

10

 

 

 

 

 

 

 

 

OP1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0

 

 

 

 

 

 

 

 

 

NZB

C57BL

AJ

BALB/cJ NZW/LJ

AKR

C2J

CBA

DBA/1J DBA/2J

LP/J

Mouse Strain

F 81.6 Upper panel, Summed oscillatory potentials (± 1 standard error) across strains. Lower panel, Mean amplitude

(± 1 standard error) of each of the first four major oscillatory potentials.

a-wave parameters

 

4

 

 

 

 

 

 

 

 

 

black

 

albino

 

 

 

brown/agouti

 

V)

3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(

 

 

 

 

 

 

 

 

 

p3

2

 

 

 

 

 

 

 

 

log Rm

 

 

 

 

 

 

 

 

1

 

done

 

 

 

 

 

 

 

 

not

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0

 

 

 

 

 

 

 

 

 

NZB

C57BL

AJ

BALB/cJ NZW/LJ

AKR

C2J

CBA

DBA/1J DBA/2J

LP/J

Mouse Strain

 

4

 

 

 

 

 

 

 

 

 

 

black

 

albino

 

 

 

brown/agouti

 

 

3

 

 

 

 

 

 

 

 

S

2

 

 

 

 

 

 

 

 

log

 

 

 

 

 

 

 

 

 

 

done

 

 

 

 

 

 

 

1

 

 

 

 

 

 

 

 

 

 

not

 

 

 

 

 

 

 

0

 

 

 

 

 

 

 

 

 

NZB

C57BL

AJ

BALB/cJ NZW/LJ

AKR

C2J

CBA

DBA/1J DBA/2J

LP/J

Mouse Strain

F 81.7 Rod photoreceptor structure and function. Upper panel, Saturated a-wave amplitude (± 1 standard error) across

strains. Lower panel, Mean (± 1 standard error) values of photoreceptor sensitivity, S, across strains.

:

905

RmP3 was not statistically different across or within strains (mean RmP3 = 266.4 ± 89.0 mV, P = 0.342). In contrast, S, the photoresponse sensitivity, differed across the three coat colors. Log S was found to be 2.43 (± 0.21), 2.84 (± 0.18), and 2.45 (± 0.16) for the black, albino, and brown/agouti strains, respectively (P < 0.0001). In addition, significant differences were found among strains for the albino and agouti strains but not among the black strains (P > 0.10).

C -M R A summary of cone-mediated responses is given in figure 81.8. Cone maximal amplitude across all strains ranged from 32.9 (± 21.0) mV to 116.5 (± 32.0) mV. Statistically different responses were not found across the black strains (77.8 ± 32 mV, P = 0.014). However, substantial differences in cone amplitude were found for the albino strains (69.6 ± 34 mV, P < 0.0001) and for the brown/agouti strains (95.4 ± 29 mV, P < 0.0001). As shown in figure 81.9, cone maximum amplitude and ERG threshold intensity were highly correlated (r = -0.93, P < 0.0001). Finally, implicit time of the major b-wave peak was not significantly different across strains (44.0 ± 5.4 ms).

R - V C -M C A comparison of maximal rodand cone-mediated amplitudes is shown in figure 81.10. In general, rodand cone-mediated

amplitudes were correlated across all strains (r = 0.60, P < 0.0001). Within individual strains, correlations ranged from +0.43 to +0.93. However, for AJ and LP/j mice, rod function and cone function were uncorrelated. This means that for these strains, cone function could not be predicted from the responses that were rod-mediated. In addition, for strains with weak correlations, a high rod amplitude did not necessarily predict a high cone amplitude. For example, in figure 81.10, the albino strain with the highest rod amplitude (Vmax) had only intermediate cone amplitudes.

General conclusions

The electrophysiological and analytical techniques based on the ERG can be powerful tools to better understand the sites and mechanisms of disease action in mouse models of ocular disease. The ERG is a commonly used technique to assess panretinal function and can be dissected to quantify and evaluate the functional integrity of different retinal layers. The ERG has been used extensively to describe the retinal phenotype in mouse models of human retinal disease and has been used to evaluate the efficacy of a broad spectrum of genetic and pharmaceutical interventions. At the present time, however, there are no internationally accepted standards for recording ERGs in mice.

 

 

 

 

 

Amplitude

 

 

 

 

160

 

 

 

 

 

 

 

 

 

V)

140

black

 

albino

 

 

 

brown/agouti

 

 

 

 

 

 

 

 

 

 

 

(

120

 

 

 

 

 

 

 

 

 

amplitude

 

 

 

 

 

 

 

 

 

100

 

 

 

 

 

 

 

 

 

80

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

cone

60

 

 

 

 

 

 

 

 

 

40

 

 

 

 

 

 

 

 

 

w8.0

 

 

 

 

 

 

 

 

 

20

 

 

 

 

 

 

 

 

 

 

0

 

 

 

 

 

 

 

 

 

 

 

NZB

C57BL

AJ

BALB/cJ NZW/LJ

AKR

C2J

CBA

DBA/1J DBA/2J

LP/J

ERG Threshold

 

0.0

 

 

 

 

 

 

 

 

intensity

–0.2

 

 

 

 

 

 

 

 

–0.4

 

 

 

 

 

 

 

 

–0.6

 

 

 

 

 

 

 

 

threshold

–0.8

 

 

 

 

 

 

 

 

–1.0

 

 

 

 

 

 

 

 

–1.2

 

 

 

 

 

 

 

 

Log

 

 

 

 

 

 

 

 

–1.4

black

 

albino

 

 

 

brown/agouti

 

 

 

 

 

 

 

 

 

 

 

 

–1.6

 

 

 

 

 

 

 

 

 

NZB

C57BL

AJ

BALB/cJ NZW/LJ

AKR

C2J

CBA

DBA/1J DBA/2J

LP/J

Mouse Strain

F 81.8 Upper panel, Mean (± 1 standard error) conemediated b-wave maximal amplitudes across strains. Lower panel,

Mean (± 1 standard error) cone ERG threshold intensity across strains.

906

td-s)

–0.2

 

 

 

 

 

 

–0.4

 

 

 

 

 

 

scot

 

 

 

 

 

 

 

 

 

 

 

 

 

(log

–0.6

 

 

 

 

 

 

 

 

 

 

 

 

 

intensity

–0.8

 

 

 

 

 

 

–1.0

 

 

 

 

 

 

threshold

–1.2

 

 

 

 

 

 

–1.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.2

1.4

1.6

1.8

2.0

2.2

2.4

cone w8la amplitude (log V)

F 81.9 Correlation between cone ERG threshold and the maximal cone b-wave amplitude across strains.

 

500

 

 

 

 

 

 

v)

400

 

 

 

 

 

 

 

 

 

 

 

 

 

(

200

 

 

 

 

 

 

amplitude

 

 

 

 

 

 

 

300

 

 

 

 

 

 

max

 

 

 

 

 

black

 

V

100

 

 

 

 

 

 

 

 

 

 

albino

 

 

 

 

 

 

 

brown/agouti

 

 

0

 

 

 

 

 

 

 

0

25

50

75

100

125

150

cone max amplitude ( V)

F 81.10 Rodversus cone-mediated function. Each data point represents the mean response with error bars for each strain. (See text for discussion.)

While there are abundant published ERG data on mutant mice, little has been published that documents retinal function across normal inbred strains without known retinopathy. In addition, little is known about how retinal function in the normal mouse alters during the aging process. Within the context of our understanding of the cellular origins of different components of the ERG, such studies could provide insights into which cells in the retina are most susceptible to aging and disease.

As a first step, we have characterized retinal function with the ERG across a range of normal inbred strains that are commonly used in vision science. While there were many subtle differences between strains that could be dismissed as normal variability, some differences were substantial and statistically significant, suggesting differences in cellular function. Some of the differences can be relatively easily

explained. For example, the albino strains were generally more sensitive to light than the pigmented and agouti strains. These differences in sensitivity are largely due to differences in ocular melanin, which absorbs light, thereby reducing the amount of light reaching the photoreceptors. The underlying mechanisms responsible for other differences in ERG parameters are not yet understood. Ongoing work in our own laboratory is focused on determining the reliability and replicability of these differences, how ERG parameters are altered during aging, and the underlying cellular variations that could cause such differences.

REFERENCES

1.Alexander K, Fishman GA, Peachy NS, Marchese AL, Tso MO: “On” response defect in paraneoplastic night blindness with cutaneous malignant melenoma. Invest Ophthalmol Vis Sci 1992; 33:477.

2.Birch DG, Hood DC, Nusinowitz S, Pepperberg DR: Abnormal activation and inactivation mechanisms of rod transduction of patients with autosomal dominant retinitis and the PRO-23-HIS mutation. Invest Ophthalmol Vis Sci 1996; 36:1603.

3.Breton ME, Montzka D: Empiric limits of rod photocurrent component underlying a-wave response in the electroretinogram. Doc Ophthalmol 1992; 79:337.

4.Breton ME, Schueller AW, Lamb TD, Pugh EN Jr: Analysis of ERG a-wave amplification and kinetics in terms of the G- protein cascade of phototransduction. Invest Ophthalmol Vis Sci 1994; 35:295.

5.Bush RA, Hawks KW, Sieving PA: Preservation of inner retinal responses in the aged Royal College of Surgeons rat: Evidence against glutamate excitotoxicity in photoreceptor degeneration. Invest Ophthalmol Vis Sci 1995; 36:2054.

6.Calderone JB, Jacobs GH: Regional variations in the relative sensitivity to UV light in the mouse retina. Vis Neurosci 1995; 12:463.

7.Carter-Dawson L, LaVail MM: Rods and cones in the mouse retina: I. Structural analysis using light and electron microscopy. J Comp Neurol 1979; 188:245.

8.Cideciyan AV, Jacobson SG: Negative electroretinograms in retinitis pigmentosa. Invest Ophthalmol Vis Sci 1993; 34:3253.

9.Ekesten B, Gouras P, Moschos M: Cone properties of the lightadapted murine ERG. Doc Ophthalmol 1998; 97:23.

10.Goto Y, Peachey NS, Ripps H, Naash MI: Functional abnormalities in transgenic mice expressing a mutant rhodopsin gene. Invest Ophthalmol Vis Sci 1995; 36:62.

11.Goto Y, Peachey NS, Ziroli NE, Seiple WH, Gryczan C, Pepperberg DR, Naash MI: Rod phototransduction in transgenic mice expressing a mutant opsin gene. J Opt Soc Am A Opt Image Sci 1996; 13:577.

12.Goto Y, Peachey NS, Ziroli NE, Seiple WH, Gryczan C, Pepperberg DR, Naash MI: Rod phototransduction in transgenic mice expressing a mutant opsin gene. J Opt Soc Am A Opt Image Sci 1996; 13:577.

13.Granit R: Two types of retinae and their electrical responses to intermittent stimuli in light and dark adaptation. J Physiol 1935; 85:421.

14.Granit R: Receptors and Sensory Perception. New Haven, CT, Yale University Press, 1955.

:

907

15.Green DG, Kapousta-Bruneau NV, Hitchcock PF, Keller SA: Electrophysiology and density of retinal neurons in mice with a mutation that includes the Pax2 locus, Invest Ophthalmol Vis Sci 1997; 38:919.

16.Griff ER: Electroretinographic components arising in the distal retina. In Heckenlively JR, Arden GB (eds): Principles and Practice of Clinical Electrophysiology of Vision. St. Louis, Mosby, 1991, pp 91–98.

17.Hetling JR, Pepperberg DR: Sensitivity and kinetics of mouse rod flash responses determined in vivo from paired-flash electroretinograms. J Physiol 1999; 516:593.

18.Heynen H, Van Norren D: Origin of the electroretinogram in the intact macaque eye: I. Vision Res 1985; 25:697.

19.Heynen H, Wachtmeister L, Van Norren D: Origin of the oscillatory potentials in the primate retina. Vision Res 1985; 25:1365.

20.Hood DC, Birch DG: The a-wave of the human electroretinogram and rod receptor function. Invest Ophthalmol Vis Sci 1990; 31:2070.

21.Hood DC, Birch DG: A quantitative measure of the electrical activity of human rod photoreceptors using electroretinography. Vis Neurosci 1990; 5:379.

22.Hood DC, Birch DG: Rod phototransduction in retinitis pigmentosa: Estimation and interpretation of parameters derived from the rod a-wave. Invest Ophthalmol Vis Sci 1994; 35: 2948.

23.Jacobs GH: Ultraviolet vision in vertebrates. Am Zool 1992; 32:544.

24.Jacobs GH, Neitz J, Deegan JF III: Retinal receptors in rodents maximally sensitive to ultraviolet light. Nature 1991; 353:655.

25.Karwoski C, Kawasaki K: Oscillatory potentials. In Heckenlively JH, Arden GB (eds): Handbook of Clinical Electrophysiology of Vision Testing. St Louis, Mosby Year Book, 1991, pp 125–128.

26.Kedzierski W, Lloyd M, Birch D, Bok D, Travis G: Generation and analysis of transgenic mice expressing P216L-substituted Rds/Peripherin in rod photoreceptors. Invest Ophthalmol Vis Sci 1997; 38:498.

27.Lyubarsky AL, Falsini B, Pennesi ME, Valentini P, Pugh EN Jr: UVand midwave-sensitive cone-driven retinal responses of the mouse: A possible phenotype for coexpression of cone photopigments. J Neurosci 1999; 19:442.

28.Marti A, Hafezi F, Lansel N, Hegi ME, Wenzel A, Grimm C, Niemeyer G, Remae CE: Light-induced cell death of retinal photoreceptors in the absence of p53. Inv Ophthal Vis Sci 1998; 39:846.

29.Menner E: Untersuchunger uber die Retina mit besonderer Berucksichtigung der ausseren Kornerschichte. Z vergl Physiol 1928; 8:761.

30.Miller RF, Dowling JE: Intracellular responses of Muller (glial) cells of the mudpuppy retina: Their relation to the b-wave of the electroretinogram. J Neurophysiol 1970; 33:323.

31.Miyake Y, Yagasaki K, Horiguchi M, Kawase Y: Onand offresponses in photopic electroretinogram in complete and incomplete types of congenital stationary night blindness. Jpn J Ophthalmol 1987; 31:81.

32.Newman EA, Odette LL: Model of electroretinogram b-wave generation: A test of the K+ hypothesis. J Neurophysiol 1984; 51:164.

33.Nusinowitz S, Nguyen L, Farber D, Danciger M: Electroretinographic evidence for reduced phototransduction gain and slowed photoreceptor recovery in albino mice with a MET450 variant in RPE65. Exp Eye Res 2003; 77(5):627– 638.

34.Nusinowitz S, Ridder W, Heckenlively JR: Electrodiagnostic techniques for visual function testing in mice. In Smith R, John SWM, Nishina PM, Sundberg JP (eds): Systematic Evaluation of the Mouse Eye: Anatomy, Pathology, and Biomethods. New York, CRC Press, 2002, pp 320–344.

35.Ogden TE: The oscillatory waves of the primate electroretinogram. Vision Res 1973; 13:1059.

36.Pardue MT, McCall MA, LaVail MM, Gregg RG, Peachey NS: A naturally occurring mouse model of X-linked congenital stationary night blindness. Invest Ophthal Vis Sci 1998; 39:2443.

37.Peachey NS, Goto Y, al-Ubaidi MR, Naash MI: Properties of the mouse cone-mediated electroretinogram during light adaptation. Neurosci Lett 1993; 162:9.

38.Peachey NS, Roveri L, Messing A, McCall MA: Functional consequences of oncogene-induced horizontal cell degeneration in the retinas of transgenic mice. Vis Neurosci 1997; 14:627.

39.Penn RD, Hagins WA: Signal transmission along retinal rods and the origin of the electroretinographic a-wave. Nature 1969; 223:201.

40.Ren JC, LaVail MM, Peachey NS: Retinal degeneration in the nervous mutant mouse: III. Electrophysiological studies of the visual pathway. Exp Eye Res 2000; 70:467.

41.Ridder W, Azimi A, Heckenlively JH, Nusinowitz S: Cataractogenesis in anesthetized mice. Curr Eye Res 2002; 75(3):365– 370.

42.Robson JG, Frishman LJ: Response linearity and kinetics of the cat retina: The bipolar cell component of the dark-adapted electroretinogram. Vis Neurosci 1995; 12:837.

43.Rohrer B, Korenbrot JI, LaVail MM, Reichardt LF, Xu B: Role of neurotrophin receptor TrkB in the maturation of rod photoreceptors and establishment of synaptic transmission to the inner retina. J Neurosci 1999; 19:8919.

44.Ruether K, van de Pol D, Jaissle G, Berger W, Tornow RP, Zrenner E, Retinoschsis-like alterations in the mouse eye caused by gene targeting of the Norrie disease gene. Invest Ophthal Vis Sci 1997; 38:710.

45.Seeliger MW, Grimm C, Stahlberg F, Friedburg C, Jaissle G, Zrenner E, Guo H, Reme CE, Humphries P, Hofmann F, Biel M, Fariss RN, Redmond TM, Wenzel A: New views on RPE65 deficiency: The rod system is the source of vision in a mouse model of Leber congenital amaurosis. Nat Genet 2001; 29(1):70–74.

46.Shaaban SA, Crognale ME, Calderone JB, Huang J, Jacobs G, Deeb SS: Transgenic mice expressing a functional human photopigment. Invest Ophthalmol Vis Sci 1998; 39:1036.

47.Sidman RL, Histochemical studies on photoreceptor cells. Ann N Y Acad Sci 1958; 74:182.

48.Sieving P: Photopic “ON” and “OFF” pathway abnormalities in retinal dystrophies. Trans Am Ophthalmol Soc 1993; 91: 701.

49.Sieving PA, Frishman LJ, Steinberg RH: Scotopic threshold response of proximal retina in cat. J Neurophysiol 1986; 56:1049.

50.Smith SB, Hamasaki DI: Electroretinographic study of the C57BL/6-mivit/mivit mouse model of retinal degeneration.

Invest Ophthalmol Vis Sci 1994; 35:3119.

51.Stockton RA, Slaughter MM: B-wave of the electroretinogram: Reflection of ON bipolar cell activity. J Gen Physiol 1989; 93:101.

52.Sugawara T, Sieving PA, Bush RA: Quantitative relationship of the scotopic and photopic ERG to photoreceptor cell loss in light damaged rats. Exp Eye Res 2000; 70:693.

53.Sun H, Macke JP, Nathans J: Mechanisms of spectral tuning in the mouse green cone pigment. Proc Natl Acad Sci U S A 1997; 94:8860.

908

54.Wachtmeister L: Oscillatory potentials in the retina: What do they reveal. Prog Retin Eye Res 1998; 17:485.

55.Wachtmeister L, Dowling JE: The oscillatory potentials of the mudpuppy retina. Invest Ophthalmol Vis Sci 1978; 17:1176.

56.Wu J, Peachey NS, Marmorstein AD: Light-evoked responses of the mouse retinal pigment epithelium. J Neurophysiol 2004; 91(3):1134–1142.

57.Yang RB, Robinson SW, Xiong WH, Yau KW, Birch DG, Garbers DL: Disruption of a retinal guanylyl cyclase gene leads to cone-specific dystrophy and paradoxical rod behavior, J Neurosci 1999; 19:5889.

58.Xu XJ, Karwoski CJ: Current source density analysis of retinal field potentials: 2. Pharmacological analysis of the b-wave and m-wave. J Neurophysiol 1994; 72:96.

:

909

This page intentionally left blank

82 Electroretinograms of Dog

and Chicken

- , , - , .

L with retinal dystrophy are increasing in importance as models of human conditions, particularly for the testing of therapeutic strategies. Spontaneously occurring retinal dystrophies are recognized in both dogs and chickens. Hereditary disease that leads to vision loss in the dog is also important because this species plays a valuable role in human life, not only as a working and service animal, tasks for which vision is required, but also as a companion animal. In addition to its use as a laboratory model for the study of retinal disease, the chicken is widely used for the study of ametropias.

This chapter will elucidate some practical aspects of canine and chicken ERGs, give examples, and show some of the changes that can be seen in inherited retinal diseases.

The canine electroretinogram

The dog is becoming more widely recognized as an important model for human retinal dystrophies. There are a number of different spontaneously occurring hereditary retinal degenerations in the dog, and this coupled with the fact that the dog eye is very similar in size to the human eye makes the canine retinal dystrophies important for the study of retinal dysfunction and the therapeutic approaches to save vision.

Electroretinography is commonly performed on dogs by veterinary ophthalmologists to investigate retinal disease in working and companion dogs and by researchers utilizing the dog as a model for human disease. The increased utilization of the dog as a model of human disease demands that the normal canine electroretinogram (ERG) is fully characterized so that this technique can be most effectively utilized.

There are some important differences between the dog and human retina. For example, the dog does not appear to have an area with predominance of cones and does not have a fovea. The dog retina does have a region called the visual streak (or area centralis) in which there is greater ganglion cell density,58 and it is this region that is used for most detailed vision. As with humans, there are many more rods in the canine retina than cones, but the exact rod-to-cone ratio has not been reported. There are some reports describing how the distribution of cones varies across the retina

although the results vary between the publications (see the review by Miller and Murphy42). The dog has dichromatic color vision having two types of cone: one with peak spectral absorbance at 429–435 nm and the other at 555 nm.31,53 Peak spectral absorption of the canine rod photopigment rhodopsin is 508 nm.31

The following section gives examples of ERGs in the normal dog and in dogs with hereditary retinal disease.

M R C ERG Techniques used to record the canine ERG are described in chapter 83. The ERGs shown in the current chapter were recorded from anesthetized dogs (typically sedated with acepromazine, induced with thiopentone, and anesthesia maintained with halothane or isoflurane delivered in oxygen). Although anesthetic agents can alter the ERG responses,36,84 anesthesia is required to immobilize the dog. Ganzfeld flash ERGs were recorded with an LKC UTAS E-3000 electrophysiology unit (LKC Technologies, Gaithersburg, MD). Although 20 minutes of dark adaptation is recommended by the standards established by the European College of Veterinary Ophthalmologists (ECVO) ERG committee,51 we find that dark-adapting the eye for at least 45–60 minutes results in greater amplitudes in the scotopic ERG. We have also shown that if a dog is examined by indirect ophthalmoscopy or fundus photographs are taken immediately prior to the ERG session, the period of dark adaptation time must be increased to at least 60 minutes to achieve ERG amplitudes comparable to those that can be recorded after 20 minutes of dark adaptation76 (if examination with bright lights had not been performed.) Typically, the pupil is maximally dilated by topical application of tropicamide or a combination of tropicamide and phenylephrine. The pupil diameter is monitored before and after the procedure because some drugs used for premedication or anesthesia can result in pupillary constriction and some individual dogs develop miosis after anesthesia, despite repeated application of mydriatics.

The selection of recording lens can influence the amplitudes and also, to some extent, the shape of the ERG recorded from dogs. In a study comparing three different electrodes, we found that significantly higher amplitudes were recorded using either a DTL fiber electrode or an ERG-Jet lens electrode compared to the amplitudes

- .:

911

recorded by using a bipolar Burian-Allen lens.40 This finding differs from the results obtained in human patients, in which the Burian-Allen lens tended to result in greater amplitudes compared to the other electrodes.21 Additionally, we demonstrated that in using monopolar electrodes, choosing a consistent position of the reference electrode is very important. When we compared amplitudes obtained by using the ERGJet lens electrode and a skin reference electrode positioned 1, 3, or 5 cm caudal to the lateral canthus of the eye we found that between the three reference electrode positions, the further caudally the electrode, the greater the amplitude.40 A study of canine perfused eyes found that the greatest ERG could be recorded in that system with a corneal contact electrode when the reference electrode was placed on the posterior sclera adjacent to the optic nerve.17 The lack of a complete bony wall to the lateral orbit in the dog may mean that there is less electrical resistance between a skin electrode positioned more posteriorly and the current generated in the retina than there would be in a human with a complete bony orbit, given that bone offers greater electrical resistance than soft tissues. These studies demonstrate the importance of standardization of equipment and technique if ERGs are to be comparable.

In addition to the effect of recording technique on ERG amplitudes, the breed and age of dog are important. Dogs represent one of the most phenotypically diverse species (compare a chihuahua with a Great Dane, for example), so it is perhaps not surprising that normal ERG amplitudes can differ considerably between breeds of dog. Amplitudes also tend to decrease with age. For any study using a particular breed of dog, it is important that an appropriate breedand age-matched control is available, particularly in trying to detect the early stages of retinal disease.

M C ERG The retina of the dog is not fully developed at birth. Retinal maturation occurs over the first couple of months of age (figure 82.1). When the eyes of puppies open at between 10 and 14 days of age, the ERG is just a low-amplitude negative waveform in response to brighter flashes of light. By 4 weeks of age, the ERG waveform is adultlike with an a-wave, a b-wave, and oscillatory potentials. Maximal amplitudes are achieved by about 7 weeks of age and appear to decrease slightly after that age as the animal matures; a- and b-wave response thresholds are at their lowest intensity by a similar age (7 weeks).

C C ERG In addition to the a- and b-waves and oscillatory potentials (figure 82.1), other components of the canine ERG have been described. The scotopic threshold response (STR) can be recorded under specific recording conditions with good dark adaptation85,86 but can be reduced by the use of some anesthetic agents.84

The early receptor potential described in other species has not been reported in the dog, probably because of the technical difficulties in recording this response.48 Similarly, there are no reports of investigation of the canine M-wave. Averaging several flashes of red light has been reported to allow the separation of a cone-derived x-wave from the b-wave.50 A photopic i-wave can be seen in the dog,66 although we have found that the selection of recording electrode is important in being able to record this response. See figure 82.5C later in the chapter for an example of a canine i-wave. Consideration of the d-wave is included in the section about canine long-flash responses.

A C ERG Canine ERGs can be analyzed similarly to those of other species. a- and b-wave amplitudes and implicit times can be measured. Soctopic and photopic intensity-response curves can be plotted, and a- and b-wave thresholds can be calculated. To allow for consistent comparison, a criterion threshold value can be selected. The Naka-Rusthon formula can be applied to fit the b-wave intensity-response curve and used to derive a value for maximal rod photoreceptor response (Vbmax), and a value for retinal sensitivity (k) may be calculated (k = the intensity that gives a response of 1/2 Vbmax).

L -F ERG D Figure 82.2 shows a typical example of a canine long-flash ERG. The stimulus for photopic ON-OFF recordings (long-flash ERGs) were as described by Sieving.73 A stimulus of 200 cd/m2 (typically, a 150to 200-ms flash duration was chosen) was presented on a background light of 34 cd/m2. The ON response has typical a- and b-waves. Following the b-wave is a plateau that varies between slightly rising (as in figure 82.4 later in the chapter) and slightly decreasing. At the onset of the OFF response, there is often a small positive deflection that is then followed by a large negative deflection similar in amplitude to the b-wave. At the trough of the negative deflection, there is a small positive deflection followed by a large positive waveform that returns to baseline. The OFF response of the dog is thus similar to that of the rat.49 This represents a response from what Granit25 classified as an excitatory (E- type) retina rather than an inhibitory (I-type) retina as in the human and the chicken (see below). It is not clear whether the small positive wave seen at the onset of the OFF response represents the equivalent of the d-wave recorded in other species, such as primates, or whether the large negative response is the equivalent of the d-wave.

E ERG C C R D -

Canine retinal dystrophies include models for retinitis pigmentosa and for Leber congenital amaurosis. The retinitis pigmentosa models in dogs are known as the progressive retinal atrophies and occur in several different

912

 

A

2 weeks

B

7 weeks

C

24 weeks

 

 

 

 

 

 

 

-2.99

 

-2.99

 

 

 

 

-2. 60

 

-2. 60

 

 

 

 

-2.00

 

-2.00

 

 

 

 

-1.60

 

-1.60

 

 

 

 

-1.19

 

-1.19

 

 

 

 

-0.80

 

-0.80

 

 

0.00

 

0.00

 

0.00

 

 

 

 

 

 

Scotopic

0.86

 

0.86

 

0.86

 

 

1.90

 

1.90

 

1.90

 

 

2.40

 

2.40

 

2.40

 

 

 

 

 

 

 

 

 

25µV

 

100µV

 

100µV

 

 

 

 

 

 

 

20mS

 

20mS

 

20mS

 

 

 

 

 

 

D

 

E

 

F

 

 

 

 

0.00

 

0.00

 

 

 

 

0.40

 

0.40

 

 

0.86

 

0.86

 

0.86

 

 

 

 

 

 

 

Photopic

1.36

 

1.36

 

1.36

 

 

1.90

 

1.90

 

1.90

 

 

2.40

 

2.40

 

2.40

 

 

 

10µV

 

 

 

 

 

 

20µV

 

 

 

 

 

 

 

 

 

 

20mS

 

20mS

 

20µV

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20mS

F 82.1 Maturation of the canine ERG. The tracings are from the same dog. Panels A, B, and C show scotopic intensity series responses, while panels D, E, and F are photopic intensity

10µV

150 mS

F 82.2 Long-flash ERG from a dog. This shows the photopic long-flash ERG from a normal adult dog. This is the result of a 150-ms flash of 200 cd/m2 superimposed on a background light of 34 cd/m2. The ON response is characterized by an a- and a b- wave. There is a plateau region while the light remains on. The OFF response is characterized by a small positive deflection followed by a large negative response, similar in amplitude to the b- wave. At the trough of the negative OFF response, there is often a small positive deflection, which is followed by a larger positive waveform that passes the baseline before returning to baseline.

series responses. Panels A and D are at 2 weeks of age, panels B and E at 7 weeks of age, and panels C and F at 24 weeks of age. Arrowheads indicate the onset of flash.

breeds of dog. The progressive retinal atrophies show genetic heterogeneity. The gene mutations underlying some of the forms have been identified. Phenotypically, the progressive retinal atrophies can be divided into earlyand lateonset forms.

Progressive retinal atrophies Some of the early-onset forms are given the phenotypic description rod-cone dysplasias because photoreceptor development becomes halted during development, and this is followed by a rapid loss of rod photoreceptors with a much slower loss of cones. The first form was described in the Irish setter breed and is known as rodcone degeneration type 1 (rcd1), 9,14 the second form was described in the collie (rcd2),81 and the third form was described in the Cardigan Welsh corgi (rcd3).32 Rcd1 is caused by a point mutation resulting in a premature stop codon in the gene encoding the rod cyclic GMP phosphodiesterase beta subunit (PDE6B).16,74 The gene mutation underlying rcd2 has not been identified, and that underlying rcd3 is a 1-bp deletion in the gene encoding the rod cyclic

- .:

913

GMP phosphodiesterase alpha subunit (PDE6A) leading to a premature stop codon.60 The mutations in PDE6A and PDE6B are most likely functional null mutations. The rod cyclic GMP phosphodiesterase enzyme requires the presence of both alpha and beta excitatory subunits for normal activity. When one subunit is missing or is nonfunctional, phosphodiesterase activity is much reduced,62 so the substrate cyclic GMP accumulates. In similar animal models, such as the rd1 mouse, it has been shown that the accumulation of cyclic GMP and the resulting opening of an increased proportion of cyclic GMP-gated channels in the cell membrane trigger apoptosis in the rod photoreceptor.34 Cones, although genetically normal, are affected by the loss of surrounding rods and are halted in their development and then degenerate slowly.9,14,15 Figure 82.3 shows representative scotopic and photopic ERG intensity series from an rcd3- affected dog. The rcd3 dogs lack rod-mediated responses at all ages. This very-early-onset abnormality suggests, as would be expected given the lack of functional rod cyclic GMP phosphodiesterase alpha subunit, that normal rod phototransduction does not develop in the affected dogs. The developmental abnormalities of cones are reflected functionally in a significant reduction of the photopic a-wave amplitude as early as 3 weeks of age (figure 82.3F). The photopic b-wave of the affected dogs is not significantly different from that of breed-matched normal controls until later in the disease process.61 Although cone function is abnormal

from a very early age, the loss of cones is relatively slow (unpublished histological findings), and sufficient vision in good lighting conditions to allow negotiation of obstacle courses is maintained for two to four years. It is of note that only a small photopic b-wave remains in these animals, and histological examination of the retina of affected dogs in this age range that still have some residual vision reveals that they have only isolated areas with residual cone photoreceptor cells apparently with just stunted inner segments.

Of the later-onset forms of progressive retinal atrophy in dogs, one form called progressive rod-cone degeneration ( prcd ) is known to be present in several different breeds.3–5 Prcd maps to canine chromosome 9,2,24,41,72 although the actual gene defect underlying it had not been published at the time of writing. In prcd, the photoreceptors mature normally, but then there is a progressive rod-led loss of photoreceptors.6 The loss of photoreceptors is reflected in a progressive reduction in ERG amplitudes. Figure 82.4 shows an example of a dog presented for early diagnosis of prcd. The rod responses are affected first,8,67 but changes are not seen until after normal maturation and probably reflect a loss of total number of photoreceptors rather than a generalized abnormality in photoreceptor function. The shape of the darkadapted waveforms are essentially normal; however, the response threshold is elevated, and the a- and b-wave amplitudes are both reduced to a similar extent (compare figure 82.4B with figure 82.4A). The photopic responses are still

 

+/+

3 week

-/-

A

B

 

 

 

 

-1.60

 

 

 

-1.19

 

 

 

-0.80

 

 

 

-0.40

 

 

 

-0.00

 

Scotopic

 

0.40

 

 

0.96

 

 

 

 

 

 

1.36

 

 

 

1.90

 

 

50µV

 

20µV

 

20mS

 

20mS

E

F

 

0.00

 

0.16

 

0.40

Photopic

0.85

1.36

 

 

1.90

 

2.40

20µV

20µV

20mS

20mS

 

F 82.3 ERGs from an rcd3 dog.

Representative

scotopic (A–D) and photopic (E–H) inensity series responses from a normal control dog (A, C, E, and G) compared to a

 

+/+

7 week

 

-/-

C

-1.60 D

 

 

 

 

-1.19

 

 

 

 

-0.80

 

 

 

 

-0.40

 

 

 

 

-0.00

 

 

 

 

0.40

 

 

 

 

0.96

 

 

 

 

1.36

 

 

 

 

1.90

 

 

 

50µV

 

 

20µV

 

 

 

 

 

20mS

 

 

20mS

G

 

0.00

H

 

 

 

 

 

 

 

0.16

 

 

 

 

0.40

 

 

 

 

0.85

 

 

 

 

1.36

 

 

 

 

1.90

 

 

 

 

2.40

 

 

 

20µV

 

 

210µV

 

20mS

 

 

20mS

PDE6A mutant/rcd3 dog (B, D, F, and H) at 3 weeks (A, B and E, F) and 7 weeks (C, D and G, H) of age. Arrowheads indicate the onset of flash.

914

well preserved at this stage (compare figure 82.4D with figure 82.4C).

Dog model of Leber congenital amaurosis Leber congenital amaurosis (LCA) is an early-onset severe retinal dystrophy with vision loss in childhood.59 Similarly to retinitis pigmentosa, it shows genetic heterogeneity.28 LCA type II results from mutations in RPE65,19,26,46,75 a gene encoding a 65-kDa protein expressed in retinal pigment epithelium (RPE) that plays a role in the visual cycle.64 A spontaneously occurring dog model of LCA type II in the briard breed has been investigated.52,82,83 The original colony that was characterized and in which the mutation in RPE65 was identified was established in Sweden; hence, the name Swedish briard dog came into use, although “Swedish briard” is not a separate breed from the briard. The mutation identified in the briard dog is a 4-bp deletion leading to a premature stop codon.78 The affected dogs have a lack of dim light vision and a variable degree of daytime vision loss. Studies in mice

A

Control

B

prcd Dog

 

 

-3.00

 

 

 

-2.00

 

 

 

-1.01

 

Scotopic

 

2.13

 

 

 

2.82

 

 

40µV

 

20µV

 

 

 

 

20mS

 

20mS

 

 

 

C

 

D

 

 

 

0.00

 

 

 

0.61

 

 

 

1.12

 

Photopic

 

1.63

 

 

 

2.13

 

 

 

 

10µV

 

10µV

 

20mS

 

20mS

 

 

F 82.4 Scotopic (A and B) and photopic (C and D) intensity series responses from a prcd dog (B and D) compared to a normal control (A and C). The dog being tested had been observed to have some subtle bilateral fundoscopic changes that were not considered to be diagnostic for PRA and was referred for ERG testing. The ERGs clearly showed a marked decrease in ERG amplitudes compared to the normal control dog, showing that the test dog had a generalized retinal dysfunction. Arrowheads indicate the onset of flash.

have shown that the lack of RPE65 protein activity means that 11-cis-retinal is not recycled from the RPE to the photoreceptors.64 There is therefore a lack of formation of visual pigment and a resultant failure in normal rod phototransduction.64 In affected dogs, there is only a slow degeneration of photoreceptors, and as the animals get older, there is a progressive accumulation of retinyl esters in the RPE.82,83 The lack of phototransduction is reflected in the ERG of affected dogs,54 as can be seen in the representative ERGs in figure 82.5. Comparison of dark-adapted with light-adapted ERG waveforms in the RPE65 dog reveal that the intensitymatched responses are very similar in amplitude, suggesting that the majority of the response recorded in the RPE65 mutant dog at this age is cone-mediated; similar findings are reported in children with RPE65 mutations37 and RPE65 knock-out mice.64 An ERG study using RPE65 knock-out mice suggested that the mutant mice have a pronounced loss of UV cone function with preservation of M cone function.20 Similar studies have not been reported in dogs. However a study utilizing double knockout mice that had a lack or functional RPE65 with either a lack of functional

A

Control

B RPE65 Dog

 

 

-3.18

 

 

-2.60

 

 

-2.00

 

 

-1.60

 

 

-1.19

 

 

-0.80

 

 

0.00

Scotopic

 

0.39

 

1.90

 

 

 

 

1.36

 

 

2.40

 

200µV

50µV

 

20mS

20mS

C

 

D

0.00

0.16

0.39

Photopic 1.36 0.85

1.90

2.40

50µV

20µV

20mS

20mS

F 82.5 Scotopic (A and B) and photopic (C and D) intensity series responses from an RPE65 mutant dog (B and D) compared with a normal control (A and C). Arrowheads indicate the onset of flash.

- .:

915

rods or a lack of functional cones showed that the major ERG response was due to a response from desensitized rods,68 although it was subsequently shown that a small cone derived response was also recordable.65

O C M This article has given only some selected examples of ERGs of dog retinal dystrophy models. There are other canine retinal dystrophy models in which the gene mutation has been described, such as X-linked PRA (due to mutations in RP GTPase regulator; RPGR mutations),87 dominantly inherited PRA (due to a mutation in the rod opsin gene),33 and achromatopsia in the cone dysplasia dog (due to a mutation in cyclic nucleotide-gated channel beta-subunit gene; CNGB3).10,68,69 There are also other canine models that have been phenotypically characterized but for which the causal gene mutation has not been identified, such as the rod dysplasia (rd ) Norwegian elkhound,7 the early retinal degeneration (erd ) Norwegian elkhound,1 and the photoreceptor dysplasia (pd ) miniature schnauzer.57 Many other naturally occurring canine retinal dystrophies remain to be characterized. The publishing of the canine genome35 and the development of tools for disease mapping mean that it is becoming progressively easier to identify the gene mutations underlying the myriad of genetic diseases that occur in pure-bred dogs. This will provide the opportunity to establish further colonies of experimental dogs for study and investigation of potential therapies for homologues of human disease.

S This article has emphasized the canine ERG in hereditary retinal disease. ERG studies in dogs are performed for other reasons, such as the investigation of ocular disease in veterinary medicine and in toxicology studies. Although the ERG of the dog has been well described in several studies, there is a need for further characterization, particularly in view of the emergence of the dog as an important model species of human diseases.

Electroretinography in the chicken

There are a few spontaneously occurring retinal dystrophies in chickens, although thus far, the gene mutation underlying only one of these diseases has been identified.

The chicken retina has a number of differences from the human retina. The retina is avascular, receiving its nutrition from the vitreous and via the choroid. Birds have a highly vascular structure called the pecten that protrudes from the surface of the optic nerve head into the vitreous. There are several theories as to the purpose of the pecten, one of which is that it is involved in supplying nutrition to the inner retina via the vitreous. The chicken has a relatively cone-rich retina compared to humans and canines. Most of the cones

contain colored oil droplets within the photoreceptor inner segments. These droplets act as spectral filters for the light that reaches the outer segments. The cones are divided into single cones and double cones. Double cones consist of a principal cone (similar in structure to a normal single cone), which contains an oil droplet, and an accessory cone, which curves around the inner segment of the principal cone and, according to some authors, only rarely contains a miniscule oil droplet,11 whereas others report that it has one or more oil droplets.79 On the basis of morphological appearance, three separate forms of double cone have been described.80 Four cone visual pigments are recognized: ultraviolet, shortwavelength, middle-wavelength, and long-wavelength. A different type of oil droplet is matched with each of the four visual pigments.11 The visual pigment in both members of the double cone is the same as that found in the long- wavelength-sensitive single cone. The reported proportion of each of the photoreceptor types in the chicken retina differs between studies. For example, Bowmaker and Knowles12 reported that double cones account for 50–60% of photoreceptors, whereas Morris47 reported that in the central retina, the ratios were 14% rods, 32% double cones, and 54% single cones and peripherally, 33% rods, 30% double cones, and 37% single cones.

M R C ERG The chicken ERGs shown in this chapter were recorded from anesthetized chickens (typically with isoflurane delivered in oxygen). The flash ERGs were recorded by using an LKC Utas 3000 electrophysiology unit (LKC) with a Ganzfeld unit. A bipolar Burian-Allen lens (Hansen Ophthalmic Development Laboratories, Coralville, Iowa) was used with the ground electrode placed in the hind leg. Conjunctival stay sutures were used to stabilize the globe and keep the recording lens in position. Hypromellose (0.25–0.5%) was used as a coupling solution for the lens. Birds have striated muscle in their iris; therefore, the pupil does not dilate with the topical parasympatholytic or sympathomimetic drugs used in mammals. Topical neuromuscular blocking drugs were used to induce mydriasis; for example, topical 1% vecuronium bromide given 20 minutes prior to the procedure.

N C ERG The chick retina is well developed at hatch. The ERG can be recorded from the chick embryo by the eighteenth day of incubation.55 After hatch, the ERG continues to mature over the first week or so.56 We have found that over the first 2–3 weeks post hatch, the a- and b-wave thresholds decrease. Figures 82.6A and 82.6C show representative scotopic and photopic ERG tracings, respectively, from a normal 7-day-old chick. The cone dominance of the chicken retina means that there is a significant cone component to the dark-adapted ERG, particularly

916

A Control

B rge bird

 

-2.40

 

-2.00

 

-1.42

 

-1.19

 

-0.79

 

-0.39

 

0.00

Scotopic

0.39

0.85

 

 

1.40

 

2.30

 

2.80

100µV

100µV

 

50mS

50mS

C

D

 

-2.40

 

-2.00

 

-1.42

 

-1.19

 

-0.79

 

-0.39

 

0.00

Photopic

0.39

 

 

0.85

 

1.40

 

2.30

 

2.80

100µV

100µV

50mS

50mS

F 82.6 Representative scotopic (A and B) and photopic (C and D) intensity series responses from normal (A and C) and rge (B and D) 7-day-old chicks. There is a major cone component to the dark-adapted ERG in response to brighter flashes of light. The rge chicks have elevated response thresholds, a lack of oscillatory potentials, and enhanced b-waves to brighter flashes of light. The photopic and scotopic ERGs are very similar, indicating that rod function is more severely affected than cone function at this stage of the disease. Arrowheads indicate the onset of flash.

those in response to brighter flashes. The light-adapted responses are of proportionally greater amplitude than would be recorded from a species with a rod-dominated retina (e.g., Mears et al.39).

L -F ERG The stimulus for the photopic ON-OFF recording (long-flash ERGs) was as described by Sieving.73

A long-flash stimulus of

200 cd/m2 (typically of

150-ms

duration) was

presented

on a background

light

of

34 cd/m2.

 

 

 

 

Utilization of

a long-flash protocol to investigate

ON

and OFF responses shows that the chicken has a positive OFF response (d-wave) (figure 82.7) similar to that of

20µV

150mS

F 82.7 Long-flash ERG of a chicken. A photopic ON-OFF response to a 150-ms flash (200 cd/m2) superimposed on a white background light of 34 cd/m2. The ON response consists of an a- and a b-wave followed by a plateau. The OFF response consists of a positive d-wave typical of the response from an I-type retina.

humans and primates (an I-type response) but unlike rats and dogs.

C ERG D The ERG changes that characterize some of the different forms of hereditary retinal degeneration have been reported in the chicken. These include retinal degeneration (rd ), retinal dysplasia and degeneration (rdd ), delayed amelanotic (dam), and retinopathy, globe enlarged (rge).

The rd phenotype is caused by a null mutation in the photoreceptor guanylate cyclase (GUCY2D) gene and is therefore a model of Leber congenital amaurosis type 1 in humans.69 The rd birds have a severe phenotype with nonrecordable ERGs under lightor dark-adapted conditions from the time of hatch.77

The rdd chicken phenotype is sex-linked and characterized by a progressive degeneration of the retina, culminating in blindness. By 3 weeks of age, homozygotes have a flat ERG, indicative of their severe loss of visual function.63 Linkage analysis mapped the rdd locus to a small region of the chicken Z chromosome with homologies to human chromosomes 5q and 9p.13

The dam chicken is characterized by a postnatal, spontaneous cutaneous amelanosis and a high incidence of blindness.22 The main ERG change observed in this phenotype is a generalized decrease in a- and b-wave amplitudes.23

Retinopathy, globe enlarged chick (rge) is autosomalrecessive18 and is due to a mutant locus on chicken chromosome one.30 Rge chicks have unusual ERG changes.44 The homozygous affected chicks have reduced vision, particularly in dim light, from hatch and lose functional vision at about one month after hatch.44 The retina slowly degenerates but has some early ultrastructural abnormalities of photoreceptor synaptic terminals.43 The ERGs are abnormal in shape from hatch, slowly deteriorate, and yet maintain relatively large amplitudes for some months after functional

- .:

917

vision loss.45 Examples of the affected birds’ scotopic and photopic ERGs are shown in figures 82.6B and 82.6D, respectively. a- and b-wave thresholds are elevated for both the darkand light-adapted ERGs (figure 82.8). The shape of the b-wave is abnormal, partly owing to the lack of oscillatory potentials. Interestingly, in response to very bright flashes of light, both the scotopic and photopic b-wave amplitudes of rge birds are supernormal for the first 6 or 7 weeks of age (see figure 82.8). Supernormal ERG amplitudes are reported in certain retinal dystrophies, including enhanced S-cone syndrome.29,38 In this condition, there is a lack of rods and a marked increase in numbers of S-cones.27 However, histological studies showed that rge chicks do not have marked alterations in photoreceptor ratios.43 Drug dissections of the ERG of rge chicks revealed that intravitreous APB (2-amino-4-phosphonobutyric acid) does not block this abnormal b-wave. In the normal control chick, APB almost completely eliminates the b-wave (figure 82.9). This finding suggests that the “b-wave” of rge chicks may be generated

differently from the normal chicken b-wave or from different cellular components. The true basis for the ERG changes in this interesting dystrophy remains to be elucidated.

S The chicken ERG reflects the fact that this species has a cone-dominated retina. Spontaneously occurring retinal dystrophies have been described in this species. The only one of these to be characterized at the molecular level, the rd mutation, provides a model for Leber congenital amaurosis type 1. Other chicken retinal dystrophies have been characterized to varying degrees at the phenotypic level, and the chromosomal locations of the underlying genetic mutation of some forms have been mapped. The presence of naturally occurring retinal dystrophies in chickens, coupled with the large size of the eye, the cone-dominated retina, and the ease of access and manipulation of the embryo, makes this an attractive model system for studying retinal gene function in higher vertebrates.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

250.0

 

-140.0

 

 

 

 

 

 

 

 

 

 

 

30.0

 

 

 

 

-120.0

 

 

 

 

 

 

 

 

 

 

 

25.0

 

 

200.0

 

-100.0

 

 

 

 

 

 

 

 

 

 

 

 

Implicit Time (mS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20.0

Amplitude (µV)

150.0

Amplitude (µV)

 

 

 

 

 

 

 

 

 

 

 

 

 

-80.0

A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-60.0

 

 

 

 

 

 

 

 

 

 

 

 

100.0

 

 

 

 

 

 

 

 

 

*

 

 

10.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-40.0

 

 

 

 

 

 

 

*

 

 

 

 

 

 

 

 

 

 

 

 

*

 

 

 

 

50.0

 

 

 

 

 

 

 

 

 

 

 

 

-20.0

 

 

 

 

 

 

 

 

 

 

5.0

 

 

 

 

 

 

 

*

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

*

*

 

 

 

 

 

 

 

 

 

 

 

 

 

*

 

 

 

 

 

 

 

 

 

 

 

0.0

 

 

 

 

 

 

 

 

 

0.0

 

 

0.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-2.0

-1.4

-1.2

-0.8

-0.4

0.0

0.4

0.9

1.4

1.9

2.4

2.8

 

 

 

Intensity (log cd-s/m²)

 

-100.0

 

 

 

 

 

 

 

 

 

 

 

30.0

 

 

200.0

 

-90.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

180.0

 

-80.0

 

 

 

 

 

 

 

 

 

 

 

25.0

 

 

160.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amplitude (µV)

-70.0

 

 

 

 

 

 

 

 

 

 

 

20.0

Implicit Time (mS)

 

140.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-60.0

 

 

 

 

 

 

 

 

*

 

 

 

Amplitude (µV)

120.0

-50.0

C

 

 

 

 

 

 

 

 

 

15.0

 

 

 

 

 

 

 

 

 

 

 

100.0

-40.0

 

 

 

 

 

 

 

*

 

 

 

 

80.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.0

 

-30.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

60.0

 

 

 

 

 

 

 

 

 

 

 

 

 

-20.0

 

 

 

 

 

 

*

 

 

 

 

5.0

40.0

 

 

 

 

 

 

*

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-10.0

 

 

 

 

*

 

 

 

 

 

 

 

 

20.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.0

 

 

 

 

 

 

 

 

 

 

0.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.0

 

 

-2.0

-1.4

-1.2

-0.8

-0.4

0.0

0.4

0.9

1.4

1.9

2.4

2.8

 

 

Intensity (log cd-s/m²)

 

 

 

 

 

 

 

 

 

 

 

 

60.0

 

 

 

 

 

 

 

 

 

 

 

*

*

50.0

 

 

 

 

 

 

 

 

 

 

*

 

 

40.0

 

 

 

 

 

 

 

 

 

 

 

 

 

(mS)

B

 

 

 

 

 

 

 

*

 

 

 

30.0

 

 

 

 

 

 

 

 

 

 

 

Time

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20.0

 

 

 

 

 

 

 

 

 

 

 

 

Implicit

 

 

 

 

 

 

*

 

 

 

 

 

10.0

 

 

 

 

 

*

 

 

 

 

 

 

 

 

 

*

*

*

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-2.0

-1.4

-1.2

-0.8

-0.4

0.0

0.4

0.9

1.4

1.9

2.4

2.8

 

 

Intensity (log cd-s/m²)

 

 

 

 

 

 

 

 

 

 

 

 

60.0

 

 

 

 

 

 

 

 

 

 

 

*

*

 

 

 

 

 

 

 

 

 

 

 

*

 

50.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

40.0

(mS)

D

 

 

 

 

 

 

 

*

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

30.0

 

 

 

 

 

 

 

 

 

 

 

Time

 

 

 

 

 

 

*

 

 

 

 

 

20.0

 

 

 

 

 

 

 

 

 

 

 

 

Implicit

 

 

 

 

*

*

 

 

 

 

 

 

10.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.0

 

-2.0

-1.4

-1.2

-0.8

-0.4

0.0

0.4

0.9

1.4

1.9

2.4

2.8

 

 

Intensity (log cd-s/m²)

F 82.8 Scotopic and photopic a- and b-wave intensityresponse and implicit time plots form normal and rge chicks at 7 days of age. Mean scotopic (A) and photopic (C) a-wave amplitude and implicit times and mean scotopic (B) and photopic (D) b-wave amplitude and implicit times. In each graph, the black solid curve represents the mean intensityresponse curve of the rge birds, and the black dashed curve represents that of the control birds. The gray solid curve represents

the intensity-implicit time curve of the rge birds, and the gray dashed curves represent the a-wave implicit time curve from normal birds. Note the increased a- and b-wave threshold of the rge birds compared to control birds. The scotopic and photopic b- wave amplitudes are supernormal in response to the brighter light intensities (above 1.4 log cd s/m2). Seven control and seven rge birds’ standard error bars are shown. (* = a significant difference at P < 0.05.)

918

A

Pre-APB

B Post-APB

 

 

-0.40

 

 

0.00

 

 

0.40

Control bird

 

0.85

 

 

1.40

 

 

2.30

 

 

2.80

 

100µV

100µV

 

50mS

50mS

C

 

D

 

 

-0.40

 

 

0.00

 

 

0.40

rge bird

 

0.85

 

 

1.40

 

 

2.30

 

 

2.80

 

100µV

100µV

 

50mS

50mS

F 82.9 The effect of intravitreal APB on a normal (A and B) and a rge (C and D) chick flash ERG. Panels A and C are preinjection intensity-response series in dark-adapted birds. Panels B and D are post injection. Note that in the normal bird APB (which blocks on-bipolar cells) eliminates the b-wave. In the rge chick, APB has very little effect on the abnormal b-wave. Arrowheads indicate the onset of flash.

REFERENCES

1.Acland GM, Aguirre GD: Retinal degenerations in the dog: IV. Early retinal degeneration (erd) in the Norwegian elkhound. Exp Eye Res 1987; 44:491–521.

2.Acland GM, Ray K, Mellersh CS, Gu W, Langston AA, Rine J, et al: Linkage analysis and comparative mapping of canine progressive rod-cone degeneration (prcd) establishes potential locus homology with retinitis pigmentosa (RP17) in humans.

Proc Natl Acad Sci U S A 1998; 95:3048–3053.

3.Aguirre GD, Acland GM: Progressive retinal atrophy in the English cocker spaniel. Trans Am Coll Vet Ophthalmol 1983; 14:104.

4.Aguirre GD, Acland GM: Variation in retinal degeneration phenotype inherited at the prcd locus. Exp Eye Res 1988; 46:663–687.

5.Aguirre GD, Acland GM: Progressive retinal atrophy in the Labrador retriever is a progressive rod-cone degeneration (PRCD). Trans Am Coll Vet Ophthalmol 1989; 20:150.

6.Aguirre GD, O’Brien P: Morphological and biochemical studies of canine progressive rod-cone degeneration. Invest Ophthalmol Vis Sci 1986; 27:635–655.

7.Aguirre GD, Rubin LF: An electrophysiologic approach for the early diagnosis of progressive retinal atrophy in the Norwegian elkhound. J Am Anim Hosp Assoc 1971; 7:136.

8.Aguirre GD, Rubin LF: Progressive retinal atrophy in the miniature poodle: An electrophysiologic study. J Am Vet Med Assoc 1972; 160:191–201.

9.Aguirre GD, Rubin LF: Rod-cone dysplasia (progressive retinal atrophy) in Irish setters. J Am Vet Med Assoc 1975; 166:157–164.

10.Aguirre GD, Rubin LF: The electroretinogram in dogs with inherited cone degeneration. Investigative Ophthalmol Vis Sci

1975; 14:840–847.

11.Bowmaker JK, Heath LA, Wilkie SE, Hunt DM: Visual pigments and oil droplets from six classes of photoreceptor in the retinas of birds. Vision Res 1997; 37:2183–2194.

12.Bowmaker JK, Knowles A: The visual pigments and oil droplets of the chicken retina. Vision Res 1977; 17:755–764.

13.Burt DW, Morrice DR, Lester DH, Robertson GW, Mohamed MD, Simmons I, et al: Analysis of the rdd locus in chicken: A model for human retinitis pigmentosa. Mol Vis 2003; 9:164–170.

14.Buyukmihci N, Aguirre GD, Marshall J: Retinal degenerations in the dog: II. Development of the retina in rod-cone dysplasia. Exp Eye Res 1980; 30:575–591.

15.Chader GJ, Liu YP, Fletcher RT, Aguirre G, Santos-Anderson R, Tso M: Cyclic-GMP phosphodiesterase and calmodulin in early-onset inherited retinal degenerations. Curr Topics Membranes Transport 1981; 15:133–156.

16.Clements PJM, Gregory CY, Petersen-Jones SM, Sargan DR, Bhattacharya SS: Confirmation of the rod cGMP phosphodiesterase b-subunit (PDEb) nonsense mutation in affected rcd- 1 Irish setters in the UK and development of a diagnostic test. Curr Eye Res 1993; 12:861–866.

17.Cringle SJ, Alder VA, Brown MJ, Yu DY: Effect of scleral recording location on ERG amplitude. Curr Eye Res 1986; 5:959–965.

18.Curtis R, Baker JR, Curtis PE, Johnston AR: An inherited retinopathy in commercial breeding chickens. Avian Pathol 1988; 17:87–89.

19.Dharmaraj SR, Silva ER, Pina AL, Li YY, Yang JM, Carter CR, et al: Mutational analysis and clinical correlation in Leber congenital amaurosis. Ophthalmic Genet 2000; 21:135–150.

20.Ekesten B, Gouras P, Salchow DJ: Ultraviolet and middle wavelength sensitive cone responses in the electroretinogram (ERG) of normal and Rpe65 -/- mice. Vision Res 2001; 41:2425–2433.

21.Esakowitz L, Kriss A, Shawkat F: A comparison of flash electroretinograms recorded from Burian Allen, JET, C-glide, gold foil, DTL and skin electrodes. Eye 1993; 7(1):169–171.

22.Fite KV, Bengston L, Doran P: Retinal pigment epithelial correlates of avian retinal degeneration: Electron microscopic analysis. J Comp Neurol 1985; 231:310–322.

23.Fulton AB, Fite KV, Bengston L: Retinal degeneration in the delayed amelanotic (DAM) chicken: An electroretinographic study. Curr Eye Res 1982; 2:757–763.

24.Goldstein O, Nelson J, Kijas J, Sidjanin D, Acland G, Aguirre G: A linkage disequilibrium map of the progressive rod cone degeneration interval [ARVO abstract]. Invest Ophthalmol Vis Sci 2004; 45:4756.

25.Granit R: Two types of retinas and their electrical responses to intermittent stimuli in light and dark adaptation. J Physiol (Lond) 1935; 85:421–428.

26.Gu SM, Thompson DA, Srikumari CR, Lorenz B, Finckh U, Nicoletti A, et al: Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nat Genet 1997; 17:194–197.

- .:

919

27.Haider NB, Naggert JK, Nishina PM: Excess cone cell proliferation due to lack of a functional NR2E3 causes retinal dysplasia and degeneration in rd7/rd7 mice. Hum Mol Genet 2001; 10:1619–1626.

28.Hanein S, Perrault I, Gerber S, Tanguy G, Barbet F, Ducroq D, et al: Leber congenital amaurosis: Comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis. Hum Mut 2004; 23:306–317.

29.Hood DC, Cideciyan AV, Roman AJ, Jacobson SG: Enhanced S cone syndrome: Evidence for an abnormally large number of S cones. Vision Res 1995; 35:1473–1481.

30.Inglehearn CF, Morrice DR, Lester DH, Robertson GW, Mohamed MD, Simmons I, et al: Genetic, ophthalmic, morphometric and histopathological analysis of the retinopathy globe enlarged (rge) chicken. Mol Vis 2003; 9:295–300.

31.Jacobs GH, Deegan JF, Crognale MA, Fenwick JA: Photopigments of dogs and foxes and their implications for canid vision. Vis Neurosci 1993; 10:173–180.

32.Keep JM: Clinical aspects of progressive retinal atrophy in the Cardigan Welsh corgi. Aust Vet J 1972; 48:197–199.

33.Kijas JW, Cideciyan AV, Aleman TS, Pianta MJ, PearceKelling SE, Miller BJ, et al: Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa. Proc Natl Acad Sci U S A 2002; 99:6328–6333.

34.Kim DH, Kim JA, Choi JS, Joo CK: Activation of caspase-3 during degeneration of the outer nuclear layer in the rd mouse retina. Ophthalmic Res 2002; 34:150–157.

35.Kirkness EF, Bafna V, Halpern AL, Levy S, Remington K, Rusch DB, et al: The dog genome: Survey sequencing and comparative analysis. Science 2003; 301:1898–1903.

36.Kommonen B: The DC-recorded dog electroretinogram in ketamine-medetomidine anaesthesia. Acta Vet Scand 1988; 29:35–41.

37.Lorenz B, Gyurus P, Preising M, Bremser D, Gu S, Andrassi M, et al: Early-onset severe rod-cone dystrophy in young children with RPE65 mutations. Invest Ophthalmol Vis Sci 2000; 41:2735–2742.

38.Marmor MF, Tan F, Sutter EE, Bearse MA Jr: Topography of cone electrophysiology in the enhanced S cone syndrome.

Invest Ophthalmol Vis Sci 1999; 40:1866–1873.

39.Mears AJ, Kondo M, Swain PK, Takada Y, Bush RA, Saunders TL, et al: Nrl is required for rod photoreceptor development. Nat Gen 2001; 29:447–452.

40.Mentzer AL, Eifler D, Montiani-Ferreira F, Tuntivanich N, Forcier JQ, Petersen-Jones SM: Influence of recording electrode type and reference electrode position on the canine electroretinogram. Doc Ophthalmol 2006; in press.

41.Miller BJ, Sidjanin DJ, Kijas J, McElwee J, Acland GM, Aguirre G: Physical and transcription mapping of the canine prcd region syntenic to human chromosome 17q24–25[ARVO abstract]. Invest Ophthalmol Vis Sci 2002; 43:3672.

42.Miller PE, Murphy CJ: Vision in dogs. J Am Vet Med Assoc 1995; 207:1623–1634.

43.Montiani-Ferreira F, Fischer A, Cernuda-Cernuda R, DeGrip WJ, Sherry D, Cho SS, et al: Detailed histopathologic characterization of the retinopathy, globe enlarged (rge) chick phenotype. Mol Vis 2005; 11:11–27.

44.Montiani-Ferreira F, Li T, Kiupel M, Howland H, Hocking P, Curtis R, et al: Clinical features of the retinopathy, globe enlarged (rge) chick phenotype. Vision Res 2003; 43:2009– 2018.

45.Montiani-Ferreira F, Petersen-Jones SM: Characterization of electroretinographic abnormalities in the retinopathy, globe enlarged (RGE) chick [ARVO abstract]. Invest Ophthalmol Visual Sci 2003; 44:4534.

46.Morimura H, Fishman GA, Grover SA, Fulton AB, Berson EL, Dryja TP: Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or Leber congenital amaurosis. Proc Natl Acad Sci U S A 1998; 95:3088–3093.

47.Morris VB: Symmetry in a receptor mosaic demonstrated in the chick from the frequencies, spacing and arrangement of the types of retinal receptor. J Comp Neurol 1970; 140:359–398.

48.Muller W, Topke H: The early receptor potential (ERP). Doc Ophthalmol 1987; 66:35–74.

49.Naarendorp F, Williams GE: The d-wave of the rod electroretinogram of rat originates in the cone pathway. Vis Neurosci 1999; 16:91–105.

50.Narfström K, Ekesten B: Electroretinographic evaluation of papillons with and without hereditary retinal degeneration. Am J Vet Res 1998; 59:221–226.

51.Narfström K, Ekesten B, Rosolen SG, Spiess BM, Pecicot CL, Ofri R: Guidelines for clinical electroretinography in the dog. Doc Ophthalmol 2002; 105:83–92.

52.Narfström K, Wrigstad A, Nilsson SEG: The briard dog: A new animal model of congenital stationary night blindness. Br J Ophthalmol 1989; 73:750–756.

53.Neitz J, Geist T, Jacobs GH: Color-vision in the dog. Vis Neurosci 1989; 3:119–125.

54.Nilsson SE, Wrigstad A, Narfström K: Changes in the DC electroretinogram in briard dogs with hereditary congenital night blindness and partial day blindness. Exp Eye Res 1992; 54:291–296.

55.Ookawa T: On the ontogenetic study of the chick ERG. Nippon Seirigaku Zasshi 1971; 33:317–318.

56.Ookawa T: The onset and development of the chick electroretinogram: The A- and B-waves. Poult Sci 1971; 50:601– 608.

57.Parshall CJ, Wyman M, Nitroy S, Acland G, Aguirre G: Photoreceptor dysplasia: An inherited progressive retinal atrophy of miniature schnauzer dogs. Prog Vet Comp Ophthalmol 1991; 1:187–203.

58.Peichl L: Topography of ganglion cells in the dog and wolf retina. J Comp Neurol 1992; 324:603–620.

59.Perrault I, Rozet JM, Gerber S, Ghazi I, Leowski C, Ducroq D, et al: Leber congenital amaurosis. Mol Genet Metab 1999; 68: 200–208.

60.Petersen-Jones SM, Entz DD, Sargan DR: cGMP phosphodiesterase-a mutation causes progressive retinal atrophy in the Cardigan Welsh corgi dog. Invest Ophthalmol Vis Sci 1999; 40:1637–1644.

61.Petersen-Jones SM, Grosjean N, Ramsey DT, Tuntivanich N: Preliminary characterization of the clinical and electroretinographic features of a PDE6A mutation in the dog [ARVO abstract]. Invest Ophthalmol Vis Sci Suppl 2000; 41:1063.

62.Piriev NI, Yamashita C, Samuel G, Farber DB: Rod photoreceptor cGMP-phosphodiesterase: Analysis of alpha and beta subunits expressed in human kidney cells. Proc Natl Acad Sci U S A 1993; 90:9340–9344.

63.Randall CJ, Wilson MA, Pollock BJ, Clayton RM, Ross AS, Bard JB, et al: Partial retinal dysplasia and subsequent degeneration in a mutant strain of domestic fowl (rdd). Exp Eye Res 1983; 37:337–347.

64.Redmond TM, Yu S, Lee E, Bok D, Hamasaki D, Chen N, et al: Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet 1998; 20:344–351.

920

65.Rohrer B, Lohr HR, Humphries P, Redmond TM, Seeliger MW, Crouch RK: Cone opsin mislocalization in Rpe65-/- mice: A defect that can be corrected by 11-cis retinal. Invest Ophthalmol Vis Sci 2005; 46:3876–3882.

66.Rosolen SG, Rigaudiere F, Legargasson JF, Chalier C, Rufiange M, Racine J, et al: Comparing the photopic ERG i-wave in different species. Vet Ophthalmol 2004; 7:189–192.

67.Sandberg MA, Pawlyk BS, Berson EL: Full-field electroretinograms in miniature poodles with progressive rod-cone degeneration. Invest Ophthalmol Vis Sci 1986; 27:1179–1184.

68.Seeliger MW, Grimm C, Stahlberg F, Friedburg C, Jaissle G, Zrenner E, Guo H, Reme CE, Humphries P, Hofmann F, Biel M, Fariss RN, Redmond TM, Wenzel A: New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis. Nat Genet 2001; 29:70–74.

69.Semple-Rowland SL, Lee NR, Van Hooser JP, Palczewski K, Baehr W: A null mutation in the photoreceptor guanylate cyclase gene causes the retinal degeneration chicken phenotype. Proc Natl Acad Sci U S A 1998; 95:1271–1276.

70.Sidjanin DJ, Lowe JK, McElwee JL, Milne BS, Phippen TM, Sargan DR, et al: Canine CNGB3 mutations establish cone degeneration as orthologous to the human achromatopsia locus ACHM3. Hum Molec Genet 2002; 11:1823–1833.

71.Sidjanin DJ, Lowe J, Mellersh C, Ostrander EA, Milne B, Sargan D, et al: Identification of a mutation responsible for hereditary cone degeneration in dog. Invest Ophthalmol Vis Sci 2002; 43:3671.

72.Sidjanin DJ, Miller B, Kijas J, Pillardy J, Malek J, Pai G, et al: Radiation hybrid map, physical map and low-pass genomic sequence of the canine prcd region on CFA9, and comparative mapping with the syntenic region on human chromosome 17. Invest Ophthalmol Vis Sci 2003; 44:1502.

73.Sieving PA: Photopic ONand OFF-pathway abnormalities in retinal dystrophies. Trans Am Ophthalmol Soc 1993; 91:701–773.

74.Suber ML, Pittler SJ, Quin N, Wright GC, Holcombe N, Lee RH, et al: Irish setter dogs affected with rod-cone dysplasia contain a nonsense mutation in the rod cGMP phosphodiesterase beta-subunit gene. Proc Natl Acad Sci U S A 1993; 90:3968–3972.

75.Thompson DA, Gyurus P, Fleischer LL, Bingham EL, McHenry CL, Apfelstedt-Sylla E, et al: Genetics and pheno-

types of RPE65 mutations in inherited retinal degeneration.

Invest Ophthalmol Vis Sci 2000; 41:4293–4299.

76. Tuntivanich N, Mentzer AL, Eifler D, Montiani-Ferreira F, Forcier JQ, Johnson C, et al: Assessment of the darkadaptation time required for recovery of electroretinographic responses in dogs after fundus photography and indirect ophthalmoscopy. Am J Vet Res 2005; 66:1798–1804.

77.Ulshafer RJ, Allen C, Dawson WW, Wolf ED: Hereditary retinal degeneration in the Rhode Island Red chicken: I. Histology and ERG. Exp Eye Res 1984; 39:125–135.

78.Veske A, Nilsson SE, Narfström K, Gal A: Retinal dystrophy of Swedish briard/briard-beagle dogs is due to a 4-bp deletion in RPE65. Genomics 1999: 57:57–61.

79.Wai SM, Yew DT: A cytological study on the development of the different types of visual cells in the chicken (Gallus domesticus). Cell Mol Neurobiol 2002; 22:57–85.

80.Wai SM, Kung LS, Yew DT: Novel identification of the different types of cones in the retina of the chicken. Cell Mol Neurobiol 2002; 22:177–184.

81.Wolf ED, Vainisi SJ, Santos-Anderson RM: Rod cone dysplasia in the collie. J Am Vet Med Assoc 1978; 173:1331– 1333.

82.Wrigstad A, Nilsson SE, Narfström K: Ultrastructural changes of the retina and the retinal pigment epithelium in briard dogs with hereditary congenital night blindness and partial day blindness. Exp Eye Res 1992; 55:805–818.

83.Wrigstad A, Narfström K, Nilsson SE: Slowly progressive changes of the retina and retinal pigment epithelium in briard dogs with hereditary retinal dystrophy: A morphological study. Doc Ophthalmol 1994; 87:337–354.

84.Yanase J, Ogawa H: Effects of halothane and sevoflurane on the electroretinogram of dogs. Am J Vet Res 1997; 58:904–909.

85.Yanase J, Ogawa H, Ohtsuka H: Rod and cone components in the dog electroretinogram during and after dark adaptation. J Vet Med Sci 1995; 57:877–881.

86.Yanase J, Ogawa H, Ohtsuka H: Scotopic threshold response of the electroretinogram of dogs. Am J Vet Res 1996; 57:361– 366.

87.Zhang Q, Acland GM, Wu WX, Johnson JL, Pearce-Kelling S, Tulloch B, et al: Different RPGR exon ORF15 mutations in canids provide insights into photoreceptor cell degeneration. Hum Mol Genet 2002; 11:993–1003.

- .:

921

This page intentionally left blank

83 Electroretinographic Testing in

Larger Animals

M studies have been performed in animals as a means to describe basic physiological response mechanisms of the retina to light stimulation. The recordings have served to expand our knowledge, not only of the normal anatomy and physiology of the retinal cells and their interactions, but also of pathological and disease processes of the eye. For the latter purpose, there have been a number of animal retinal diseases to study. In addition, there are now genetically modified animals, that is, knockout animals, that are used to examine the role of single genes and amino acids or as direct models of human retinal diseases.

Electroretinogram (ERG) testing in animals larger than rats and mice has been performed for research purposes in guinea pigs,11 pigeons,25 ground squirrels,26 chickens,21,74

rabbits,73,75,79 cats,38,56,67,76,77 dogs,4,28,32,58,69,84 sheep,29 and

monkeys,20,24,68,78 as well as other species. It appears that animals larger than these, such as pigs, cows, and horses, are seldom used for pure research, owing to impracticalities, such as the higher housing costs and the increased risks for both investigators and animals in conjunction with the testing procedures.

Virtually all kinds of objective ERG studies that are routinely done in humans can be performed in larger animals. One major difference is the need for anesthetics in these animals,1,52,71 which can have a direct effect on the configuration of the ERG recordings. Depending on the choice of anesthetics, the effects range from minimal, when using only hypnotics, to more severe when using barbiturates or volatile anesthetics such as halothane.33,41

Another difference in larger animals (mammals), except primates, is that they are dichromats. Two types of cones are prevalent, varying in numbers and topographic location in the retina.64 Rods dominate most retinas of larger animals, although cones dominate for lizards, birds, and squirrels. These variations in photoreceptor types and distribution between species cause the resultant normal ERG curves to vary markedly between species. Another anatomic variable is the “extra” refractile cell layer located in the inner part of the choroid of many domestic species. It is called tapetum lucidum (dogs and cats) or tapetum cellulosum (horse and cattle) and is found in the superior half of the fundus. This layer increases the effect of incident light on the photoreceptors

and results in increased retinal illuminance.60 It also increases stray light, effects that significantly affect ERG recordings.66

Today, the application for electroretinography in larger animals has broadened, due to the objective nature of the test. This is true especially in the field of veterinary ophthalmology, in which electrophysiological studies in domesticated animals such as dogs, cats, and horses are more or less routinely performed. Although more sophisticated studies such as pattern,58 focal, multifocal,66 bright-flash, double-flash, and ON and OFF17 and d.c. ERGs31,33 are used only in a few specialized centers across the world in larger animals, most veterinary ophthalmology specialty clinics today have equipment to record flash ERGs.57

Flash ERGs are most commonly used in dogs in veterinary medicine. For example, ERGs are used as a routine screening procedure for quick evaluation of retinal function, prior to cataract surgery, and in the evaluation of acute blinding diseases or trauma.2,52 There is an increasing need for flash ERGs to be performed more frequently in horses as well.30 Complete cataracts, especially in foals, is a frequent indication for equine ERGs. Also in trauma cases, ERGs are indicated and in conjunction with intraocular inflammatory disease entities such as uveitis, the most common cause of blindness in the horse.

ERGs are also used for the screening of hereditary eye disease, mainly in dogs, sometimes in cats, and less frequently in Appaloosa horses. In the pedigree dog population, there is a high incidence of generalized, hereditary photoreceptor disorders, collectively termed progressive retinal atrophy (PRA) (table 83.1). Among photoreceptor disorders that have been more specifically studied and documented in dogs are rod-cone dysplasias,12,37,82 rod dysplasia,5 early rod degeneration,2 photoreceptor dysplasia,59 progressive rod-cone degeneration,7,45 cone degeneration,4 and congenital retinal dystrophy.55

Some of these photoreceptor disorders are congenital and cause early-onset severe visual impairment or blindness.55 Others do not cause blindness until the animal is several years old and are often not diagnosed until late in the disease process.1,4,13,54 Early diagnosis of these bilateral, generalized hereditary retinal diseases is advocated. It is recommended that such studies be used prior to breeding, thus reducing the

:

923

T 83.1

Reported hereditary photoreceptor diseases in the canine, feline, and equine species

 

 

 

Onset of

ERG

 

 

 

Fundus

Diagnostically

Species

Breed

Disease Name

Abnormalities

Informative

 

 

 

 

 

Canine

Irish setter

Rod-cone dysplasia type 1

3–4 months

6 weeks

 

Collie

Rod-cone dysplasia type 2

3–4 months

6 weeks

 

Norwegian elkhound

Rod dysplasia

5 months

6 weeks

 

Norwegian elkhound

Early rod degeneration

6 months

6 weeks

 

Miniature schnauzer

Photoreceptor dysplasia

2–5 years

6 weeks

 

Belgian shepherd

Unclassified

11 weeks

4 weeks

 

Portuguese waterdog

Progressive rod-cone degeneration

3–6 years

1.5 years

 

Miniature and toy poodle

Progressive rod-cone degeneration

3–5 years

9–10 months

 

English cocker spaniel

Progressive rod-cone degeneration

4–8 years

18–24 months

 

American cocker spaniel

Progressive rod-cone degeneration

3–5 years

9 months

 

Labrador retriever

Progressive rod-cone degeneration

4–6 years

12–15 months

 

Tibetan terrier

Progressive retinal atrophy

12–18 months

10 months

 

Miniature longhaired dachshund

Progressive retinal atrophy

5–7 months

4 months

 

Alaskan malamute

Cone degeneration

NR

6 weeks

 

Akita-inu

Progressive retinal atrophy

5–18 months

10 months

 

Irish wolfhound

Progressive retinal atrophy

2–3 years

NR

 

English setter

Progressive retinal atrophy

<7 years

NR

 

Tibetan spaniel

Progressive retinal atrophy

3–4 years

NR

 

Papillon

Progressive retinal atrophy

2–6 years

18 months

 

Siberian husky

X-linked progressive retinal atrophy

6–12 months

18 months

 

Samoyed

X-linked progressive retinal atrophy

2–4 years

16–24 months

 

Briard

Congenital retinal dystrophy (RPE65 mutation)

4–6 years

5 weeks

 

Cardigan Welsh corgi

Progressive retinal atrophy

NR

NR

Feline

Abyssinian

Rod-cone dysplasia

4–5 weeks

5 weeks

 

Abyssinian

Rod-cone degeneration

1–2 years

8–12 months

Equine

Appaloosa

Congenital stationary night blindness

NR

1 month

NR = Not recorded.

For further reading, see references 13, 14, 45, 47, 50, and 81.

frequency of affected animals with genetic defects prevalent in the population.1,50

Owing to an increasing awareness among clinicians and pedigree dog and cat owners and breeders, it is likely that diagnostic ERGs will be performed more frequently in the future. In this regard, there has been debate regarding the use and misuse of ERGs in dogs,6 and ways have been proposed to resolve this problem: the establishment of referral centers with specific competency in ERG procedures where more comprehensive procedures are routinely performed, enabling researchers and clinicians a more focused approach to diagnostics of retinal disease processes in companion animals.46

Specific procedures needed in working with larger animals

ERGs in awake, restrained, or even freely moving animals have also been described.36,62,72 Although the recording of ERG should not be a painful procedure by itself, it requires patient cooperation. This cooperation is not attainable in conscious animals and therefore, to obtain reliable results, heavy sedation or general anesthesia is advocated. This not only prevents movement artifacts, such as blinks, but also

reduces stress. Further, it allows for positioning of the eye in relation to the light source and recording electrodes without causing discomfort or pain.

A number of anesthetics have been used for electrophysiological studies in larger animals and specific effects shown on various electrophysiological parameters. It is not the aim of this chapter to give detailed recommendations regarding specific anesthetic procedures for various species or breeds. The choice of anesthetic regime depends on many factors, such as the user’s experience with a specific anesthetic, the training of involved personnel, equipment availability, the species of animal being studied, and the electrophysiological effects to be investigated. See table 83.2 for a list of anesthetic protocols used in documented studies in larger animals.

Assessment of vision is performed prior to sedation or the induction of anesthesia. This is not always an easy procedure, given the lack of verbal communication and the animal’s ability to compensate for reduced visual capacity by increased use of tactile and auditory sensations. The behavior in walking a maze and the cotton ball test in both dark and lighted environments are integral parts of the visual examination procedure.49 A general examination of the

924

T 83.2

Anesthetics used and described in the literature for some larger animal species in conjunction with ERG studies

Species

Ref. No.

Anesthetics

Dosage and Route of Application

Canine

63

Short-acting barbiturate

IV (NR)

 

 

+ succinyl chloride

10–20 mg/kg IV**

 

23

Thiamylal sodium

17.5 mg/kg IV

 

 

+ succinylcholine chloride

10–20 mg IV**

 

65

Acepromazine maleate

1 mg/kg IM

 

 

+ numorphan

0.4 mg/kg IV*

 

33, 35

Ketamine hydrochloride

1.04–1.32 mg/kg IM

 

 

& xylazine

8.6–10.5 mg/kg

 

31

Glycopyrrolate bromide

0.01 mg/kg IV

 

 

+ medetomidine hydrochloride

15 mg/kg IM

 

 

+ ketamine hydrochloride

1.5 mg/kg (after 20 minutes) IV

 

 

+ vecuronium bromide

0.2 mg/kg IV**

 

43

Pentobarbital sodium

26 mg/kg IV

 

 

+ halothane

Inhalation*

 

7

Short-acting thiobarbiturate

IV (NR)

 

 

+ halothane

Inhalation*

 

82, 44

Acepromazine maleate

1 mg/kg IV

 

 

+ halothane

Inhalation*

 

70

Acepromazine maleate

0.22 mg/kg IV

 

 

+ isoflurane

Inhalation*

 

71

Acepromazine maleate

0.1 mg/kg IM

 

 

+ thiamylal sodium

10 mg/kg IV

 

 

+ halthane

Inhalation*

 

69

Oxymorphone

0.02 mg/kg IM

 

 

+ isoflurane

Inhalation*

 

32

Glycopyrrolate bromide

0.01 mg/kg IV

 

 

+ thiamylal sodium

15 mg/kg IV

 

 

+ pancuronium bromide

0.1 mg/kg/45 min**

 

59

Thiamylal sodium

15 mg/kg IV (NR)

 

 

+ halothane

Inhalation*

 

58

Glycopyrrolate bromide

0.01 mg/kg IV

 

 

+ thiamylal sodium

15 mg/kg IV

 

 

+ pancuronium bromide

0.1 mg/kg IV

 

 

+ 25% oxygen & 75%

Inhalation**

 

 

nitrous oxide

 

 

28

Isoflurane

Inhalation*

 

 

& nitrous oxide

 

 

16

Glycopyrrolate bromide

0.01 mg/kg IV

 

 

+ thiamylal sodium

15 mg/kg IV

 

 

+ pancuronium bromide

0.1 mg/kg IV**

 

83, 84

Ketamine

5 mg/kg IV

 

 

+ vecuronium bromide

40 mg/kg IV

 

 

+ 25% oxygen & 75%

Inhalation**

 

 

nitrous oxide

 

 

34

Glycopyrrolate bromide

0.01 mg/kg IV

 

 

+ thiopental sodium

15–20 mg/kg IV

 

 

+ pancuronium bromide

0.1–0.2 mg/kg/h

 

 

+ 70% nitrous oxide & 30%

Inhalation**

 

 

oxygen

 

 

1, 39

Halothane or isoflurane

Inhalation*

 

9

Sodium thiopental

15 mg/kg IV

 

 

+ halothane

Inhalation*

 

61

Ketamine hydrochloride

5 mg/kg

 

 

+ medetomidine hydrochloride

0.04 ml/kg IM

 

14, 19

Propofol

6 mg/kg IV

 

 

+ isoflurane or halothane

Inhalation*

:

925

T 83.2 (continued)

Species

Ref. No.

Anesthetics

Dosage and Route of Application

Feline

15, 37

Alphaxalone

IV (to effect)

 

 

& alphadolone acetate

 

 

 

+ halothane

Inhalation*

 

41, 77

Urethane

1.0–1.3 g/kg, Infusion: 1.92 g/h

 

 

+ halothane + nitrous

Inhalation

 

 

oxide/carbon gas mixture

For long term (up to 3 days):

 

 

+ heparin, atropine,

50 IU, 2.5 mg, 4.7 g, & 240 mg/kg;

 

 

anhydrous -glycose &

4 ml/h of 100 ml solution for infusion

 

 

urethane mixture

 

 

8, 68

Ketamine hydrochloride

10–25 mg/kg IM

 

 

& xylazine

1–2.5 mg/kg IM

 

17, 48

Thiopental sodium

8 mg/kg IV

 

 

+ isoflurane or halothane

Inhalation*

 

76

Ketamine hydrochloride

10–20 mg/kg IM

 

 

+ xylazine

0.33 mg/kg IM

 

 

+ ketamine hydrochloride

Infusion: 10 mg/kg,

 

 

& glucose & sodium chloride

10 g, 0.45 g & 0.56 g in 250 ml of solution

 

 

& potassium chloride

 

 

10

Medetomidine hydrochloride

0.1 ml/kg IM

 

 

+ ketamine hydrochloride

5 mg/kg IM

 

 

(50 mg/ml)

 

Equine

30

Detomidine hydrochloride

0.015 mg/kg IV

Rabbit

44

Ketamine hydrochloride

30 mg/kg IV

 

 

+ urethane

1.4 g/kg IP

 

73

Pentobarbital (60 mg/ml)

1.25–1.75 IV

 

 

+ pentobarbital in Ringer’s

Infusion: 20–30 ml/h

 

 

solution (2 mg/ml)

 

Guinea pig

11

Xylazine

5 mg/kg

 

 

& ketamine hydrochloride

35 mg/kg IM

Ground squirrel

26

Xylazine

7 mg/kg

 

 

& ketamine hydrochloride

70 mg/kg IM

Rat

18

Fluanisonum (10 mg/ml)

0.3 ml/kg

 

 

& fentanyl (0.1315 mg/ml)

of mixture IP

 

27

Sodium pentobarbital

5 mg/100 g IP

Pigeon

25

Chloral hydrate

410 mg/kg IM

Chicken

74

Ethyl carbamate

1.5 g/kg IP

Pig

80

Halothane

Inhalation*

Note: Glycopyrrolate and atropine are both anticholinergic drugs used primarily to prevent salivary secretions and to inhibit the bradycardic effect of vagal stimulation often seen in conjunction with general anesthesia in dogs and cats. The dose of atropine is not indicated in the table but is routinely used at 0.02–0.04 mg/kg IV, IM, or SQ in the dog and cat. For further information and instructions, see Muir WW, Hubbell JAE, Skarda R (eds): Handbook of Veterinary Anesthesia, ed 2. St. Louis, Mosby-Year Book, 1995.

+ = Given after induction or after a specific time. & = Given in combination.

*= Intubation needed.

**= Intubation and artificial respiration needed.

= For terminal procedures. NR = Not recorded.

926

F 83.1 Computerized Ganzfeld ERG system for use in larger animals. Suitable adjunct utilities are demonstrated on the table: a deflatable cushion that aids in apposition of the head, a tray for electrodes, instruments used for stay suturing, and ophthalmic medications (methyl cellulose, phenylephrine hydrochloride, and atropine).

animal and more specific eye exams are thereafter performed. The latter includes menace testing, testing of dazzle and pupillary light reflexes, ophthalmoscopy, and slit-lamp biomicroscopy. The ERG requires dilatation, and ophthalmoscopy and biomicroscopy are best done in the dilated eye. These initial examinations can be performed prior to premedication, after premedication, or after the induction of general anesthesia. In dogs and cats, these examinations are easily performed with the animal sitting on a table in a calm, dark environment. Induction of general anesthesia or deep sedation is then performed, the pupils are dilated if this was not done previously, and the animal is moved to the ERG facility (figure 83.1).

For larger animals such as horses, it is recommended to provide sedation before any specific eye exams are performed. Due to higher risks in relation to general anesthesia in this species, it is recommended that ERGs be performed in the heavily sedated standing horse.30 After light sedation and eye exams, deeper sedation is provided and possibly regional anesthesia (topical anesthesia and auriculopalpebral nerve block for eyelid akinesia) in order for the corneal electrodes to be inserted.

It is important to be aware of species variation as to type of anesthetics that are suitable to use as well as dosages (see table 83.2). Species may differ in their reactions to anesthetic agents, which also results in variations in the ERG responses obtained. Interpretation of the recorded ERG response must therefore always be done with the type of animal species studied and type of anesthesia used. ERG signals of animals also vary with age, as in human patients, with higher amplitudes in younger animals compared to those of older individuals and smaller amplitudes in animals of advanced age. Further, as was previously pointed out, there are species and breed variations as to the general configuration of the ERG responses mainly due to anatomic and physiological variations between species. It is not possible to directly compare

ERG recordings from a miniature poodle to those of a Labrador retriever, even when the same anesthetic protocol is used in both breeds of dog. Similarly, ERG recordings from dogs are different from those of cats, even when the same type of anesthetic is used. Cats have higher amplitudes and shorter implicit times in their a- and b-wave responses compared to similar recordings in dogs. Species variations are clearly seen when rodent ERGs are compared to recordings in some larger animals. Rats, for instance, have marked oscillatory potentials (OPs), while the OPs are prevalent but not as marked in cats under similar recording conditions, that is, similar state of retinal adaptation, color of light stimuli, intensity of light stimuli, and type of anesthesia.

Individual testing protocols, therefore, need to be established for each animal species studied by ERG. Normal baseline values should be obtained for each laboratory where ERG studies are performed in each species, each breed, and at least three age groups (juvenile, adult, and elderly).

Indications for flash a.c. (alternating current) ERGs may vary from simple preoperative recordings to evaluate gross retinal function in dogs with complete cataracts to extensive studies of newly discovered retinal disease processes. ERGs are often needed in conjunction with toxicological screening of the effects of various drugs and compounds and, as was previously described, in the early diagnosis of hereditary retinal disease. For these indications, except the first type, precise and standardized procedures are needed, a minimum being the evaluation of rod and cone function and the process of dark adaptation.1,4,22,47 More extended testing procedures are often also used, such as the study of scotopic threshold responses, OPs, and retinal sensitivity. These more extended studies should, however, be performed as adjunct tests to a standardized testing procedure.

Guidelines for larger animals

Guidelines for larger animals have so far been published only for dogs. The International Society for Veterinary Ophthalmology initiated this work and, together with the European College of Veterinary Ophthalmology, established a working committee for this endeavor. The procedures for ERGs in dogs were approved at the First European Conference of Veterinary Visual Electrophysiology in Vienna in 2000, and the guidelines were published in Documenta Ophthalmologica in 2002.52 These guidelines take the varying needs, previously described, for ERGs into account by providing two sets of recommendations for use in dogs: one short protocol, which is intended for rapid evaluation of gross retinal function in animals that are about to undergo cataract surgery or, for instance, to evaluate retinal versus central blindness, and a more elaborate protocol that is intended as part of a diagnostic process in the evaluation of retinal function. The second, more elaborate protocol is a longer procedure in

:

927

F 83.2 Preparation for simultaneous bilateral ERGs. The dog is lying on its chest with the electrodes connected. Three conjunctival stay sutures have been placed at the limbus and fastened to the skin with surgical tape. The apposition of the contact lens electrodes and the position of the eyes are checked by using a large dentists’ mirror.

which rod function and cone function are tested separately. This diagnostic ERG test protocol can be used for studies of newly discovered photoreceptor disorders, in toxicological studies, and in the early diagnosis and testing for generalized inherited photoreceptor disorders (see table 83.1). It is the author’s opinion that the same set of guidelines that have been described and published for dogs can be used in cats owing to physiological and anatomical similarities of retinal function and structure between the two species. The second, longer type of ERG protocol has many similarities to the human protocol published as the standard for clinical ERG (latest version published in 2004).40

The guidelines include the use of short white-flash ERGs, no more than 5 ms long, utilizing full-field light stimulation. Commercial or custom-made Ganzfeld stimulators are used that aim at obtaining a uniform distribution of the stimulating light across the retina in order to be able to measure the contributions of the entire rod and cone populations (figure 83.2). Pupils are maximally dilated during the recording session using mydriatics; 1% atropine (Isopto-Atropin) will produce dilation lasting over days, depending on animal species and frequency of instillation. If shorter dilation is required, 1% tropicamide hydrochloride (Mydriacyl) and 10% phenylephrine hydrochloride (Neosynephrine) work well and last only 3–5 hours. The use of white light is recommended. Neutral-density filters are used to attenuate the light. The choice of unilateral or simultaneous bilateral ERG recordings will depend on the species, the capacity of the equipment, and the indication for performing the ERG.

Contact lens electrodes are recommended. The most frequently used ones are gold-ring electrodes (ERG Jet Lens,

F 83.3 The dog is under general anesthesia and intubated. A bipolar Burian Allen corneal contact lens is in place and cushioned on the cornea with methylcellulose.

F 83.4 A DTL microfiber electrode is used in the standing horse. Note the thin microfiber stretched in the tearfilm along the lower eyelid margin. (Source: Komaromy AM, et al: Vet Ophthalmol 2003; 6:27–33. Used by permission.)

Universo Plastique, La Chaus-de-Fonds, Switzerland) and Burian Allen bipolar lens electrodes built specifically for the species and age (Hansen Ophthalmic Development Laboratory, Iowa), especially in dogs and cats (figure 83.3). Several laboratories design their own monopolar or bipolar lens electrodes. DTL microfiber electrodes (Retina Technologies, Scranton, PA) are useful because they do not need to be fitted onto the eye (figure 83.4). If the electrode is stretched across the cornea, the responses are large but sensitive to the position of the fiber on the cornea, which will change if the animal blinks. When the electrode is placed in

928

the palpebral sac, DTL electrode recordings are stable, but amplitudes are lower. For reference and ground electrodes, platinum subdermal needle electrodes are often used (Grass Instrumental Division, Astro-Med., Inc., West Warwick, RI).

The use of conjunctival stay sutures at the limbus to stabilize the globe, or other adequate means, is recommended during the ERG procedure. Both eyelids must be open during the examination, and the corneas must be protected by using a nonirritating protective and wetting solution, such as 0.5% methyl cellulose.

Proper oxygenation and ventilation must be maintained throughout the examination, and orotracheal intubation is used when the animals are under general anesthesia. Body temperature must be controlled and kept stable at 38–39°C. As was previously pointed out, pupils must be fully dilated throughout the examination, and evaluation of pupil size must be conducted at the beginning and at the end of the testing procedure.

For both the short and longer protocols, the dogs (and cats) are prepared and anesthetized in ambient light. The recommended short protocol is as follows:

1.Test retinal function in ambient light using a white standard flash (SF = 2–3 cd s/m2).

2.Turn off the light and test retinal function within the first minute of dark adaptation using white SF.

3.Test retinal function again after 5 minutes of dark adaptation using white SF.

Using this short protocol in a normal animal provides the examiner with a low-amplitude photopic ERG recording and lowand higher-amplitude scotopic recordings. This protocol does not allow for separation of rod function and cone function but gives an answer to the question of whether there is retinal function or not. Every lab will have to evaluate its ERG responses obtained from animal patients in comparison with those obtained under similar conditions in a group of previously tested normal animals of the same species and age group.

For a more elaborate diagnostic ERG protocol, rod function and cone function are tested separately. It is important to note that prior to the ERG examination, the animal should not have undergone fundus photography or fluorescein angiography or have been out in bright sunlight. Although the currently recommended protocol for dogs starts with evaluation of the dark-adapted responses, the choice of whether to begin with scotopic or photopic conditions is up to the user, as long as the adaptation times are met. The longer protocol is as follows:

1. Dark-adapt the animal for 20 minutes while evaluating rod function and the dynamic process of dark adaptation every 4 minutes (at 1, 4, 8, 12, 16, and 20 minutes of

dark adaptation) using a low level of white light (0.02– 0.03 cd s/m2).

2. Test the mixed rod and cone responses to a single highintensity flash of white light (using 2–3 cd s/m2).

3.Light-adapt the animal for 10 minutes, using white background light in a Ganzfeld dome or similar equipment, with an intensity of 30–40 cd/m2 at the level of the stimulated eye. Thereafter, test cone function using white SF stimulus.

4.Perform the cone flicker test using 30 Hz of white light stimuli or higher-intensity frequencies.

The OPs can be extracted from the high-intensity white light stimulus response, with filtering of the signals, using a low filter setting at 70–100 Hz. This can be done as a separate recording or, it the software is available, mathematically during analysis.

Testing sessions using the second, more elaborate testing protocol result in a set of ERGs (figure 83.5) that are evaluated as to a- and b-wave amplitude and timing characteristics. Further, the process of dark adaptation is studied. These parameters are compared to the responses of normal animals of the same species, breed, and age group. To compare results of recordings from normal and tested animals, similar anesthetic procedures must have been used in the patient and in all animals of the test group.

A scheme for rapid evaluation of obtained results has been proposed involving a flowchart for the various procedures.47,51 The amplitude and implicit time parameters for the studied animal are plotted on a chart, in which the median level for each testing parameter for normal dogs is given and the first and ninety-ninth or fifth and ninety-fifth percentiles are indicated as limits of normality.

Reports of ERGs should include a display of the animal’s own ERG traces alongside the traces of a normal, agematched animal of the same breed and anesthetized by using the same anesthetic protocol.

Correlation of ERG test results with clinical findings

It is important to realize that electrophysiological testing is a complementary way of obtaining a diagnosis in relation to a possible retinal functional problem and that ERGs cannot be interpreted in isolation. The results from a thorough history of the patient and knowledge of the specific hereditary diseases prevalent in the breed are important factors to take into account. Also, the results from visual behavior testing and the general and more specific ocular examinations performed are needed in order to obtain a correct diagnosis.

In dogs and cats with known hereditary disease entities, the majority of animals that are tested by using ERGs have a normal fundus appearance, are relatively young, and are

:

929

F 83.5 Results from an actual ERG recording session using the recommended protocol in a normal 2-year-old Labrador retriever dog but extending the recording session. A1, Photopic single flash recording after preparation of the dog. B1–B7, Scotopic ERGs recorded at 1, 4, 8, 12, 16, 20, and 24 minutes using -2.0 log cd s/m2 of white light, respectively. Note the increase in

often in their first years of breeding. For these, diagnostic ERGs, specifically evaluating rod and cone function, are of utmost importance. The papillon dog breed is an example of a breed that is affected by a hereditary rod-cone degeneration of late onset and slow progression. Fundus appearance and behavioral testing can be normal up to 2–6 years of age, but electrophysiologically, rod function is abnormal at the age of 0.8–1.5 years. In the papillon retinal disease, it appears that cone function is normal for several years, until late in the disease process, allowing the dog normal visual behavior in daylight conditions and thus hiding clinical symptoms of this progressively blinding disease. Moreover, fundus appearance is difficult to evaluate in many papillon

b-wave amplitudes during the recording session. C1–C3, Scotopic ERGs using 0, 0.3, and 0.6 log cd s/m2, respectively. D1–D3, Scotopic 10and 30-Hz flicker recordings, respectively. E1–E3, Photopic recordings at 5, 30, and 50 Hz, respectively, after 10 minutes of light adaptation (background light: 37 cd/m2) using white light stimuli at 0 log cd s/m2.

dogs, owing to great variations in the normal fundus appearance of this breed, varying from generalized darkly pigmented fundus to a subalbinotic fundus. Both types of fundi have no or only very small numbers of tapetal cells, making the ophthalmoscopic evaluation difficult. This is an example in which ERG testing is essential in order to obtain an accurate and comparably early diagnosis.51

In the briard dog retinal dystrophy, with the RPE65 null mutation, the situation is different. Affected dogs are night blind from birth and are severely visually impaired also in daylight. A quivering nystagmus is usually observed in affected dogs after the age of 6–7 weeks. Fundus appearance is normal until early middle age (3–4 years), when there is a

930

F 83.6 Actual, bilateral ERGs in an RPE65 null mutation dog treated in the right eye (OD) by subretinal gene transfer 6 weeks previously.53 The left eye (OS) was not treated. Panels A and B are lowand high-intensity scotopic responses, respectively, and panels C and D are photopic responses (5 and 30 Hz, respectively).

generalized vascular attenuation and sometimes fundus color changes and spotting. Scotopic ERGs are nonrecordable, and photopic responses are severely reduced or nonrecordable. A tentative diagnosis can, in most cases, be made by using clinical observations, such as behavioral studies and ophthalmic exams. The diagnosis is then verified by using ERG testing in 5- to 7-week-old puppies.55

Hereditary photoreceptor diseases in companion animals are most often bilateral and progressive. Thus, unilateral focal or generalized retinopathies are in general due to inflammatory or circulatory causes, and not hereditary. Various nondiagnostic ERG changes may be observed in the affected eye. In cases in which ERG results are borderline as to limits of normality, it is wise to recommend a follow-up ERG in most animals, within 6–12 months, owing to the progressive nature of most of these disorders.

Simultaneous bilateral ERG recordings are valuable to perform in conjunction with screening for hereditary eye disease,61 since the diseases are mostly bilateral but can be asymmetric. Bilateral recordings are also valuable in conjunction with unilateral treatment studies53 (figure 83.6).

I would like to thank the following for valuable discussions, comments, and advice on this chapter: Doctors Vaegan, Bertel Kommonen, Ron Ofri, and John Dodam. I am grateful for the secretarial assistance provided by Debbie Becker.

REFERENCES

1.Acland G: Diagnosis and differentiation of retinal diseases in small animals by electroretinography. Semin Vet Med Surg (Small Animal) 1988; 3:15–27.

2.Acland GM, Aguirre GD: Retinal degeneration in the dog: IV. Early retinal degeneration (ERD) in Norwegian elkhounds. Exp Eye Res 1987; 44:491–521.

3.Aguirre GD: Electroretinography in veterinary ophthalmology. J Am Anim Hosp Assoc 1973; 9:234–237.

4.Aguirre GD: Rod and cone contributions to the canine electroretinogram. PhD thesis. University of Pennsylvania, Philadelphia, 1975.

5.Aguirre G: Retinal degeneration in the dog: I. Rod dysplasia. Exp Eye Res 1978; 26:233–253.

6.Aguirre G: Electroretinography: Are we misusing an excellent diagnostic tool? Vet Comp Ophthalmol 1995; 5:2–3.

7.Aguirre GD, Acland GM: Variation in retinal degeneration phenotype inherited at the prcd locus. Exp Eye Res 1988; 46:663–687.

8.Baro JA, Lehmkuhle S, Dratz KE: Electroretinograms and visual evoked potentials in long-term monocularly deprived cats. Invest Ophthalmol Vis Sci 1990; 31:1405–1409.

9.Beltran WA, Chahory S, Gnirs K, Escriou C, Blot S, Clerc B: The electroretinographic phenotype of dogs with golden retriever muscular dystrophy. Vet Ophthalmol 2001; 4:277– 282.

10.Bragadottir R, Narfström K: Lens sparing pars plana vitrectomy and retinal transplantation in cats. Vet Ophthalmol 2003; 6:135–139.

11.Bui BV, Armitage JA, Vingrys AJ: Extraction and modeling of oscillatory potentials. Doc Ophthalmol 2002; 104:17–36.

12.Buyukmihci N, Aguirre G, Marshall J: Retinal degeneration in the dog: II. Development of the retina in rod-cone dysplasia. Exp Eye Res 1980; 30:575–591.

13.Clements PJM, Sargan DR, Gould DJ, Petersen-Jones SM: Recent advances in understanding the spectrum of canine generalized progressive retinal atrophy. J Small Anim Pract 1996; 37:155–162.

14.Curtis R, Barnett KC: Progressive retinal atrophy in miniature longhaired dachshund dogs. Br Vet J 1993; 149:71–85.

15.Curtis R, Barnett KC, Leon A: An early-onset retinal dystrophy with dominant inheritance in the Abyssinian cat: Clinical and pathological findings. Invest Ophthalmol Vis Sci 1987; 28:131–139.

16.Dawson WW, Kommonen B: The late positive retinal potential in dogs. Exp Eye Res 1995; 60:173–179.

17.Ekesten B, Narfström K: Cone positive off-response in normal and dystrophic cats. Doc Ophthalmol 1999; 97:9–21.

18.El Azazi M, Wachtmeister L: The postnatal development of the oscillatory potentials of the electroretinogram: I. Basic characteristics. Acta Ophthalmol 1990; 68:401–409.

19.Ford MM, Bragadottir R, Rakoczy EP, Narfström K: Gene transfer in the RPE65 null mutation dog: Relationship between construct volume, visual behavior and electroretinographic (ERG) results. Doc Ophthalmol 2003; 107:79–86.

20.Fortune B, Cull G, Wang L, Buskirk MV, Cioffi GA: Factors affecting the use of multifocal electroretinography to monitor function in a primate model of glaucoma. Doc Ophthalmol 2002; 105:151–178.

21.Gallemore RP, Steinberg RH: Light-evoked modulation of basolateral membrane Cl- conductance in chick retinal pigment epithelium: The light peak and fast oscillation. J Neurophysiol 1993; 70:1669–1680.

22.Gouras P: Electroretinography: Some basic principles. Invest Ophthalmol 1970; 9:557–569.

23.Gum GG, Gelatt KN, Samuelson DA: Maturation of the retina of the canine neonate as determined by electroretinography and histology. Am J Vet Res 1983; 45:1166–1171.

:

931

24.Hare WA, Ton H: Effects of APB, PDA, and TTX on ERG responses recorded using both multifocal and conventional methods in monkey. Doc Ophthalmol 2002; 195:189– 222.

25.Hodos W, Ghim MH, Potocki A, Fields JN, Storm T: Contrast sensitivity in pigeons: A comparison of behavioral and pattern ERG methods. Doc Ophthalmol 2002; 104:107–118.

26.Jacobs GH, Calderone JB, Sakai T, Lewis GP, Fisher SK: An animal model for studying cone function in retinal detachment. Doc Ophthalmol 2002; 104:119–132.

27.Jiang CJ, Hansen RM, Reynaud X, Fulton AB: Background adaptation in a rat model of retinopathy of prematurity. Doc Ophthalmol 2002; 104:97–105.

28.Jones RD, Brenneke CJ, Hoss HE, Loney ML: An electroretinogram protocol for toxicological screening in the canine model. Toxicol Lett 1994; 70:223–234.

29.Knave B, Persson HE, Nilsson SEG: The effect of barbiturate on the retinal functions: II. Effect on the c-wave of the electroretinogram and the standing potential of the sheep eye. Acta Physiol Scand 1974; 91:180–186.

30.Komaromy AM, Andrew SE, Sapp HL Jr, Brooks DE, Dawson WW: Flash electroretinography in standing horses using the DTLTM microfiber electrode. Vet Ophthalmol 2003; 6:27–33.

31.Kommonen B: The DC-recorded dog electroretinogram in ketamine-medetomidine anesthesia. Acta Vet Scand 1988; 29:35–41.

32.Kommonen B, Dawson WW, Parmer R: Pigment epithelial function in canine retina. Am J Vet Res 1991; 52:1341– 1344.

33.Kommonen B, Karhunen U, Raitta C: Effects of thiopentone, halothane-nitrous oxide anesthesia compared to ketaminexylazine anesthesia on the DC-recorded dog electroretinogram. Acta Vet Scand 1988; 29:23–33.

34.Kommonen BK, Kylma T, Karhunen U, Dawson WW, Penn JS: Impaired retinal function in young Labrador retriever dogs heterozygous for late onset rod-cone degeneration. Vision Res 1997; 37:365–370.

35.Kommonen B, Raitta C: Electroretinography in Labrador retrievers given ketamine-xylazine anesthesia. Am J Vet Res 1987; 48:1325–1331.

36.Kotani T, Kurosawa T, Numata Y, Izumisawa Y, Satoh H, Brooks DE: The normal electroretinogram in cattle and its clinical application in calves with visual defects. Prog Vet Comp Ophthalmol 1993; 3:37–44.

37.Leon A, Hussain AA, Curtis R: Autosomal dominant rod-cone dysplasia in the Rdy cat: II. Electrophysiological findings. Exp Eye Res 1991; 53:489–502.

38.Linsenmeyer RA, Steinberg RH: Delayed basal hyperpolarization of cat retinal pigment epithelium and its relation to the fast oscillation of the DC electroretinogram. J Gen Physiol 1984; 83:213–232.

39.Majji AB, Humayun MS, Weiland JD, Suzuki A, D’Anna SA, de Juan E: Long-term histological and electrophysiological results in an inactive epiretinal electrode array

implantation in dogs. Invest Ophthalmol Vis Sci 1999; 40:2073–2081.

40 Marmor MF, Holder GE, Seeliger MW, Yamamoto S: Standard for clinical electroretinography (2004 update). Doc Ophthalmol 2004; 108:107–114.

41.Millar TJ, Vaegan, Arora A: Urethane as a sole general anaesthetic in cats used for electroretinogram studies. Neurosci Lett 1989; 103:108–112.

42.Millichamp NJ, Arden GB: Transretinal mass receptor potentials recorded from the canine retina in vitro. Am J Vet Res 1989; 50:1710–1714.

43.Millichamp NJ, Curtis R, Barnett KC: Progressive retinal atrophy in Tibetan terriers. J Am Vet Med Assoc 1988; 192:769–776.

44.Mori T, Pepperberg DR, Marmor MF: Dark adaptation in locally detached retina. Invest Ophthalmol Vis Sci 1990; 31:1259–1263.

45.Narfström K: Progressive retinal atrophy in the Abyssinian cat: Clinical characteristics. Invest Ophthhalmol Vis Sci 1985; 26:193–200.

46.Narfström K: Electroretinography in veterinary medicine: Easy or accurate? Vet Ophthalmol 2002; 5:249–251.

47.Narfström K, Andersson B-E, Andreasson S, Gouras P: Clinical electroretinography in the dog using Ganzfeld stimulation: A practical method of examining rod and cone function. Doc Ophthalmol 1995; 90:279–290.

48.Narfström K, Arden G, Nilsson SEG: Retinal sensitivity in hereditary retinal degeneration in Abyssinian cats: Electrophysiological similarities to man and cat. Br J Ophthalmol 1989; 73:516–521.

49.Narfström K, Bjerkas E, Ekesten B: Visual impairment. In Peiffer RL, Peterson-Jones S (eds): Small Animal Ophthalmology: A Problem Oriented Approach, ed 3. London, Saunders, 2001, pp 103–176.

50.Narfström K, Ekesten B: Diseases of the canine ocular fundus. In Gelatt KN (ed): Veterinary Ophthalmology, ed 3. Philadelphia, Lippincott, Williams & Wilkins, 1991, pp 887–910.

51.Narfström K, Ekesten B: Electroretinographic evaluation of papillon dogs with and without hereditary retinal degeneration. Am J Vet Res 1998; 59:221–226.

52.Narfström K, Ekesten B, Rosolen S, Spiess BM, Percicot CL, Ofri R: Guidelines for clinical electroretinography in the dog. Doc Ophthalmol 2002; 105:83–92.

53.Narfström K, Katz M, Bragadottir R, Seeliger M, Boulanger A, Redmond TM, Lai C-M, Rakoczy EP: Functional and structural recovery of the retina after gene therapy in the

RPE65 null mutation dog. Invest Ophthalmol Vis Sci 2003; 44:1663–1672.

54. Narfström K, Wrigstad A: Clinical, electrophysiological and morphological changes in a case of hereditary retinal degeneration in the papillon dog. Vet Ophthalmol 1999; 2:67– 74.

55.Narfström K, Wrigstad A, Ekesten B, Nilsson SE: Hereditary retinal dystrophy in the briard dog: Clinical and hereditary characteristics. Prog Vet Comp Ophthalmol 1994; 4:85–92.

56.Nelson R, Kolb H, Famiglietti EV Jr, Gouras P: Neural responses in the rod and cone systems of the cat retina: Intracellular records and procion stains. Invest Ophthalmol 1976; 15:946–953.

57.Ofri R: Clinical electrophysiology in veterinary ophthalmology: The past, present and future. Doc Ophthalmol 2002; 104:5–16.

58.Ofri R, Dawson WW, Gelatt KN: Visual resolution in normal and glaucomatous dogs determined by pattern electroretinogram. Prog Vet Comp Ophthalmol 1993; 3:111–116.

59.Parshall CJ, Wyman M, Nitroy S, Acland G, Aguirre G: Photoreceptor dysplasia: An inherited progressive retinal atrophy of miniature Schnauzer dogs. Prog Vet Comp Ophthalmol 1991; 1:187–203.

60.Rodiek RW: The Vertebrate Retina. San Francisco, WH Freeman, 1973, p 259.

932

61.Rosolen SG, Rigaudiere F, Lachapelle P: A practical method to obtain reproducible binocular electroretinograms in dogs. Doc Ophthalmol 2002; 105:93–103.

62.Rosolen SG, Rigaudiere F, Saint-Macary G, Lachapelle P: Recording of photopic electroretinogram from conscious adult Yucutan micropigs. Doc Ophthalmol 1990; 98:197–205.

63.Rubin LF: Clinical electroretinography in dogs. J Am Vet Med Assoc 1967; 151:1456–1469.

64.Samuelson DA: Ophthalmic anatomy. In Gelatt KN (ed): Veterinary Ophthalmology, ed 3. Philadelphia, Lippincott, Williams & Wilkins, 1991, pp 117–134.

65.Sandberg MA, Pawlyk BS, Berson EL: Full-field electroretinograms in miniature poodles with progressive rod-cone degeneration. Invest Ophthalmol Vis Sci 1986; 27:1179–1184.

66.Seeliger MW, Narfström K: Functional assessment of the regional distribution of disease in a cat model of hereditary retinal degeneration. Invest Ophthalmol Vis Sci 2000; 41:1998–2005.

67.Sieving A, Frishman LJ, Steinberg RH: Scotopic threshold response (STR) of the proximal retina in the cat. J Neurophys 1986; 56:1048–1061.

68.Sieving P, Wakabayashi K: Comparison of rod threshold ERG from monkey, cat and human. Clin Vision Sci 1991; 6:171–179.

69.Sims MH, Brooks DE: Changes in oscillary potentials in the canine electroretinogram during dark adaptation. Am J Vet Res 1990; 51:1580–1586.

70.Sims MH, Laratta LJ, Bubb WJ, Morgan RV: Waveform analysis and reproducibility of visual-evoked potentials in dogs. Am J Vet Res 1989; 50:1823–1828.

71.Spiess B: Elektroretinographie beim Beagle: Methodik und normalwerte.

Inaugural-dissertation, University of Zurich, Schwitzerland, 1990, p 34.

72.Strain GM, Claxton MS, Olcott BM, Turnquist SE: Visualevoked potentials and electroretinograms in ruminant with thiamine-responsive polioencephalomalacia or suspected listerioris. Am J Vet Res 1990; 51:1513–1517.

73.Textorius O, Gottvall E: The c-wave of the direct-current- recorded electroretinogram and the standing potential of the albino rabbit in response to repeated series of light stimuli of different intensities. Doc Ophthalmol 1992; 80:91–103.

74.Ulshafer RJ, Allen C, Dawson WW, Wolf ED: Hereditary retinal degeneration in the Rhode Island red chicken: I. Histology and ERG. Exp Eye Res 1984; 39:125–135.

75.Vaegan: Electroretinograms and pattern electroretinograms of pigmented and albino rabbits. Clin Vision Sci 1992; 7:305–311.

76.Vaegan, Anderton PJ, Millar TJ: Multifocal, pattern and full field electroretinograms in cats with unilateral optic nerve section. Doc Ophthalmol 2000; 100:207–229.

77.Vaegan, Graham SL, Goldberg I, Millar TJ: Selective reduction of oscillatory potentials and pattern electroretinograms after retinal ganglion cell damage by disease in human or by kainic acid toxicity in cats. Doc Ophthalmol 1991; 77:237–253.

78.Viswanathan S, Frishman LJ, Robson JG: Inner-retinal contributions to the photopic sinusoidal flicker electroretinogram of macaques. Doc Ophthalmol 2002; 105:223–242.

79.White MP, Hock PA: Effects of continuous darkness on ERG correlates of disc shedding in rabbit retina. Exp Eye Res 1992; 54:173–180.

80.Witzel DA, Smith EL, Beerwinkle KR, Johnson JH: Arsanilic acid-induced blindness in swine: Electroretinographic and visually evoked responses. Am J Vet Res 1976; 37:521–524.

81.Witzel DA, Smith EL, Wilson RD, Aguirre GD: Congenital stationary night blindness: An animal model. Invest Ophthalmol Vis Sci 1978; 17:788–795.

82.Wolf ED, Vainisi SJ, Santos-Anderson R: Rod-cone dysplasia in the collie. J Am Vet Med Assoc 1978; 173:1331–1333.

83.Yanase J, Ogawa H, Ohtsuka H: Rod and cone components in the dog electroretinogram during and after dark adaptation. J Vet Med Sci 1995; 57:877–881.

84.Yanase J, Ogawa H, Ohtsuka H: Scotopic threshold response of the electroretinogram of dogs. Am J Vet Res 1996; 57:361–366.

:

933

This page intentionally left blank

rats,9,33,36,68,72,87,94,137

84 Visual Evoked Potentials in

Animals

T potential (VEP) is used to assess visual performance in a wide variety of animals. A recent literature search found that in the last 25 years, VEPs were

recorded from mice,35,44,61,67,85,89,97,121

guinea pigs,118,119 turtles,79 fish,12 birds,88 rabbits,81,82

cats,84,86,215 dogs,4,113,132 swine,134 sheep,16,111 cows,112,120

monkeys,10,133,138 baboons,107 and great apes.11 A small subset of the references is listed for each species. The specific species chosen for investigation was based on the experimental question asked and the availability of the species. For example, rats are a readily accessible lab animal with a short growth cycle and were used extensively to study the effects of drugs on the visual system. Because of this, the most common species employed in VEP studies was the rat. Monkeys, the second most common species investigated with VEPs, was studied because of its close anatomical relationship to humans. Thus, the VEP has been investigated in many different species for many different reasons.

Because of the extensive literature on VEPs in animals, this chapter will focus on only two species: mice and monkeys. The monkey literature will be reviewed because it reveals important information concerning the recording of VEPs in humans. The origin of the individual VEP components under various stimulus conditions has been investigated in monkeys. The mouse has recently become the model for many different retinal diseases. The reasons for this are many. For example, the mouse has a short life span, so the course of a disease can be followed in a relatively short time. Furthermore, mice can be bred with different retinal diseases, and treatments for these retinal diseases can be perfected in these mice models. The visual evoked potential has the potential to be employed to follow the course and treatment of diseases that affect the visual system. Thus, these two species appear to be the most pertinent to the understanding of the visual system of the human.

The visual evoked potential

The visual evoked potential is a gross electrical potential recorded from the visual cortex in response to a visual stimulus. That is, a visual stimulus results in the excitation of many cells in the cortex, and the summed activity of these cells is recorded as the VEP on the scalp. In all species, two

anatomical constraints determine the location in the visual field from which a VEP can be recorded: the location of the visual cortex with respect to the surface of the skull and the number of cortical cells devoted to a given region of the visual field.

Owing to the cortical magnification factor (M) and the anatomy of the visual cortex, the majority of the VEP response is from the central visual field in mice, monkeys, and humans. The M determines the number of cells in the visual cortex devoted to analyzing a specific area of the visual field. The M is the linear extent of cortex in millimeters corresponding to one degree of visual angle. In animals with retinas that have a concentrated area of cones (e.g., monkeys and humans), the M is the greatest where the cone concentration is the highest and decreases with eccentricity. In humans, M at the fovea is 5.6 mm per degree (mm/deg), and at 10 degrees from the fovea, the M is 1.5 mm/deg.99 Other estimates of M for the human fovea range up to 15.1 mm/deg.17,24,99 Estimates of M in monkeys range from 13 to 30 mm/deg at the fovea.18,20,122 In mice, the cortical magnification factor is about 0.016 mm of cortex per degree of visual field.21, 89 Wagor et al.130 demonstrated that the M in the mouse is the highest near the vertical midline and decreases by a factor of 2 at 30 degrees from the midline

(i.e., from 0.027 to 0.013 mm/deg). They

suggested that

this results from a higher concentration of

ganglion cells

devoted to the visual field near the midline. This could result in more cortical space being devoted to the central visual field.

The cortical anatomy can also play a role in the VEP response. In humans, the peripheral visual field is found at deeper locations in the calcarine fissure. The central visual field projects to the most posterior aspect of the striate cortex. This is the area closest to the scalp, and so electrodes placed over this area would be more effective at recording activity from the central visual field. In mice and monkeys, the striate cortex (area 17 or V1) is relatively flat and exposed on the surface of the brain.18,21,122, 130 This allows for VEP recordings in mice and monkeys from a large extent of the visual field. Thus, in mice and monkeys, the VEP depends more on M than on the cortical anatomy. Since the VEP depends on the number of cells in the visual cortex responding and M is the greatest near the vertical midline for mice

:

935

and the fovea in monkeys, the VEP is principally a function of the central visual field in the mouse and monkey.

Visual pathway anatomy

To understand the visual evoked potential, a brief review of the anatomy and physiology of the mouse and monkey visual pathway is necessary. A more complete summary can be found in texts devoted to anatomy and physiology.40,65,110 The following paragraphs will summarize information that is known about the retina, lateral geniculate nucleus, and striate visual cortex that are important in the origin of the visual evoked potential.

R The photoreceptors of the retina are stimulated by light that passes through the cornea, the lens, the vitreous, and several layers of the retina (figure 84.1). The primary function of the photoreceptors is phototransduction, the conversion of the energy of light into a neuroelectrical

F 84.1 Histological section of a macaque monkey retina. (Courtesy of MLJ Crawford.)

response. The photoreceptors alter their membrane potential (i.e., hyperpolarize) in response to light stimulation. There are roughly 120 million photoreceptors scattered across the primate retina, each responsive to stimulation of a discrete area of the visual field. There are four types of photoreceptors (i.e., rods and S-, M-, and L-cones) in the primate retina (i.e., old world primates and humans), which respond optimally to different wavelengths of light. The cones have their highest concentration in the fovea of the retina. The cone concentration decreases with distance from the fovea but never reaches zero. Rods are not found in the center of the fovea but are most concentrated about 20 degrees from the fovea. Owing to the anatomy of the fovea, this area is specialized for processing high spatial frequency and color information.

The mouse retina is rod dominated with few cones identified. Estimates of cone percentages in the mouse retina range from 1% to 10%, with newer techniques suggesting approximately 3% of the photoreceptors are cones.14,69,106 Morphologically, the cones of the mouse are indistinguishable from those of higher mammals.14 The mouse retina does not have an area centralis (i.e., an area of concentrated cones) or a visual streak. Carter-Dawson and LaVail,14 after examining the posterior pole, equator, and periphery, concluded that the cone concentration was about 3% in all areas. A study employing both electroretinograms and psychophysical testing suggested that there are two different cone types in the mouse.48 One cone has a peak spectral sensitivity at 510 nm, and the other is in the ultraviolet region of the spectrum at about 370 nm. Using the same ERG methodology as with the mouse, Jacobs et al.48 also identified these two cone types in gerbils, rats, and gophers.

The information from the photoreceptors is then processed though the retina, and finally, retinal ganglion cells are stimulated. This processing of visual information in the retina results in electrical changes in the tissue that can be recorded as a mass potential called the electroretinogram. Under certain recording conditions, the electroretinogram can be observed in the visual evoked potential waveform.

There are approximately 1.2 million retinal ganglion cells that give rise to the primate optic nerve. Thus, there is a convergence of information from the photoreceptors to the retinal ganglion cells. Each retinal ganglion cell processes a specific set of visual properties (e.g., spatial, temporal, color, and luminance information) and relays that information to higher visual centers. The primate has two broad classes of retinal ganglion cells: M (Pa) and P (Pb) ganglion cells. The cells in each class process similar types of visual information. In general, M cells carry information specific for low- spatial-frequency, high-temporal-frequency, low-contrast luminance objects, and P cells carry information specific for high-spatial-frequency, low-temporal-frequency, highcontrast color objects. About 80% of retinal ganglion cells

936

are P cells. P cells are concentrated in the fovea, where there is little convergence of information.131 That is, one cone may project to a single retinal ganglion cell in the fovea, whereas in the periphery, many cones may project to a single ganglion cell. The percentage of M cells increases with retinal eccentricity. The P cells project to the parvocellular layers of the LGN, and the M cells project to the magnocellular layers of the LGN.

Each mouse retina has from 48,000 to 65,000 ganglion cells.23,37 Similar to primates, it has been suggested that mice have different classes of ganglion cells based on their cell body size.23 The receptive fields of the retinal ganglion cells of the mouse have the classic center-surround arrangement found in other mammals. The size of the mouse ganglion cell receptive field is more than a log unit larger than that of the primate. This would suggest that the visual acuity of the mouse is more than 1 log unit less than that of primates.

L G N The lateral geniculate nucleus (LGN) of the primate is a small nucleus, containing roughly 1.3 million neurons, located in the lateral and posterior aspect of the thalamus. Thus, there is roughly a 1 : 1 correspondence of retinal ganglion cells to LGN cells. The LGN of old-world primates and humans has six layers. The layers are numbered 1 to 6 starting ventrally (figure 84.2). Layers 1 and 2 are the magnocellular layers (M), and layers 3–6 are the parvocellular layers (P). Each layer lies in register with those above and below it. Between these layers and ventral to the LGN are a small number of cells referred to as intercalated or I neurons.139 The receptive field properties of LGN cells are primarily determined by their inputs, that is, the retinal ganglion cells. Thus, the magnocellular layers

process visual information concerned with low spatial frequencies, high temporal frequencies, low contrast, and luminance. The parvocellular layers process visual information concerned with high spatial frequencies, low temporal frequencies, high contrast, and color. The parvocellular layers developed later evolutionarily than the magnocellular layers.

In general, retinal ganglion cells located in the nasal retina project to the contralateral LGN, and those found in the temporal retina project to the ipsilateral LGN. The ipsilateral fibers terminate in layers 2, 3, and 5, while the contralateral fibers terminate in layers 1, 4, and 6. Thus, approximately 50% of the retinal ganglion cells decussate at the optic chiasm to innervate the contralateral LGN. This results in the monocular VEPs having similar amplitudes at the cortex.

Ganglion cells from the macula project to the most posterior aspect of the LGN. The anterior LGN receives input from ganglion cells located in the peripheral retina. The ganglion cells in the superior retina project to the medial LGN, and those in the inferior retina project to the temporal LGN. Thus, the LGN has a retinotopic arrangement that results in neighboring cells in the LGN processing information from contiguous areas of the visual field.

In the mouse, Drager and Olsen23 and Balkema and Drager7 identified 2.6% of the total ganglion cell axons that projected to the ipsilateral lateral geniculate nucleus of the thalamus. Thus, over 97% of the axons decussate at the optic chiasm in the mouse. However, those ganglion cells with receptive fields located in binocular regions of the visual field (i.e., the central 30–40 degrees) had a somewhat higher percentage (approximately 9%) of axons that remained ipsilateral. The ipsilaterally projecting axons

F 84.2 Left, Vertical section of a macaque monkey LGN. Right, Interconnections with the retinas. (See text for details.) (LGN section courtesy of MLJ Crawford.) (See also color plate 57.)

:

937

F 84.3 Left, Striate cortex of a macaque monkey. Right, Interconnections with the LGN and the extrastriate cortex. (Cortex section courtesy of MLJ Crawford.)

demonstrate a divergence of connections in the LGN and occupy 14 –18% of its volume.58 The divergence of the axons at the level of the LGN may be responsible for the amplitude of the VEP from the ipsilateral eye being as much as half that of the contralateral eye.89 As in higher mammals, the projection onto the LGN follows a retinotopic arrangement.31

S C The primate striate cortex is about 2 mm thick and can be divided into six layers (figure 84.3). The striate cortex of macaques covers roughly 1300 mm2 of total surface area47 and has roughly 200,000 neurons per square millimeter of cortex.83 There is a large amount of information divergence from the LGN to the estimated 260 million neurons in the cortex. This divergence has a significant impact on the VEP recording.

The different layers of the LGN (i.e., magnocellular and parvocellular) project to specific layers in the cortex.13,62 The six layers of the cortex are numbered 1–6, starting at the pial surface and proceeding to the white matter. Some of these layers are further subdivided. The magnocellular layers of the LGN project to layer 4ca of the striate cortex, and the parvocellular layers project to layers 4cb and 4a. LGN inputs to layer 4 alternate from the right and left eyes, producing ocular dominance columns. Cells above and below layer 4 typically receive input from both eyes.

A significant amount of information is available concerning the intricacies of the striate cortical pathways in primates. The following is a brief summary. The superficial layers receive input from layer 4 and relay this information to higher cortical areas. The deeper layers (5 and 6) project back to subcortical nuclei (e.g., LGN and pulvinar). Layer 4ca projects to layer 4b and then to areas V2 and V5 (MT). Layer 4cb projects to superficial layers 2 and 3, which then project to area V2. Cells in layers 2 and 3 can be further grouped on the basis of their response to cytochrome oxidase staining.135 Cells that stain for cytochrome oxidase have a high metabolic rate, and these cells are grouped together in clusters referred to as blobs. The projection from layer 4cb terminates in blobs in layers 2 and 3. A third projection channel originates in the middle of layer 4 (i.e., contains both M and P pathway input) and projects to the interblob zones (i.e., areas between the blobs) of layers 2 and 3. The information is then relayed to area V2. Thus, several parallel channels of information flow through the striate cortex. These pathways carry different types of information and terminate in different extrastriate areas.

Cells in the striate cortex are arranged retinotopically as in the LGN. Thus, two cells located next to one another in the cortex process information from areas of the visual field located next to one another. Furthermore, there is a significant divergence of information from the macula to the

938

cortex (i.e., cortical magnification or M). The divergence results in more cortical cells devoted to processing macular information than peripheral information. Approximately half of the striate cortex is devoted to processing information from the central 10 degrees of visual field.122 Since most of the cortical cells are devoted to the macula, the VEP is principally a macular response.

In the human, the macula projects to the most posterior aspect of the calcarine fissure in the occipital lobe. The peripheral visual field projects to more anterior locations in the calcarine fissure. This results in the macular projection on the striate cortex being closest to the surface of the brain and producing the major component of the VEP. In the monkey, more of the striate cortex is exposed on the surface of the brain lateral to the midline. Thus, in the monkey, the macular projection also produces a major component of the VEP.

The mouse geniculocortical afferents project from the LGN to the primary visual cortex or area V1.21,22,130 Area V1, like the LGN, has a retinotopic arrangement.21,32,108,130 Single-cell microelectrode studies have indicated that as the midline is approached in area V1, the cells’ receptive fields move temporally in the visual field. Additionally, the superior visual field is represented posteriorly in area V1. The lateral one third of area V1 receives binocular input from the central 30–40 degrees of the upper portion of each visual hemifield.

Several studies have delineated the extent of area V1 in the mouse.21,23,32,108,126,130 Drager26 showed a map of area V1 with relation to external landmarks of the skull. Area V1 is located at the most posterior edge of the cerebral cortex. It is about 2 mm wide and 1.5–2.0 mm in the anteroposterior direction. The medial edge of area V1 is about 2 mm from the sagittal suture. Surrounding area V1 is area V2. All published maps of area V1 agree with

Drager.32,108,126,130

All of the physiological classes of striate cortical cells that have been identified in cats and monkeys (i.e., centersurround cells, simple cells, complex cells, and hypercomplex cells) have also been observed in the mouse.21,45,46,63 The receptive field properties of these cells are similar in the different species.

Based on single-cell recordings, extrastriate areas have also been identified in the mouse cortex. Wagor et al.130 identified two extrastriate areas (V2 and V3) having complete or near complete representations of the contralateral visual field. However, the cortical map that he displayed (Figure 8 in Wagor et al.130) indicates that areas V2 and V3 are considerably smaller than area V1. Thus, their contribution to the VEP is limited. Based on the mouse and monkey anatomy, a normal VEP requires a normal central visual pathway from the retina to the striate cortex.

Monkey visual evoked potential

The visual evoked potential has been used as a tool to study the visual system of normal and abnormal monkeys. Initially, the effects of different stimuli were determined on the VEP in monkeys.51,74,127,129 Subsequently, the effects of different treatments on the monkey visual system were determined with the VEP. Animal models of amblyopia,6,10,124,138 encephalitis,80,96 glaucoma,49,64 Parkinson’s disease,26 laser retinal damage,92,93,100–103 and lead and PCP toxicity60,66 have been investigated.

F VEP Several different kinds of stimuli have been employed to produce the VEP. The stimulus chosen will depend on the question being asked. Stimuli can consist of flashes of light, checkerboard patterns, square wave gratings, or sine wave gratings. Examples of normal VEP responses from monkeys to several stimuli are shown in figures 84.4, 84.5, and 84.6. Electrode placement can have a significant impact on the waveform. For these data, the active electrode was placed 2 cm lateral to the midline and 1 cm anterior to the nuchal crest. The reference electrode was placed at the vertex, and the ground was placed on the midline of the forehead. The monkey (Macaca fasicularis) was anesthetized with ketamine (10 mg/kg IM) and paralyzed with Norcuron (30 mg/kg IV). Supplemental doses of Norcuron (10 mg/kg) were used as needed. The animal was artificially ventilated (Engler 1000), and the body temperature was maintained with a heating pad. The pupils were dilated with 2.5% phenylephrine and 1% tropicamide. Heart rate, blood pressure, and expired CO2 were monitored.

Figure 84.4 shows the VEP response to a flash of light (i.e., the fVEP; N = 100). The stimulus was a 1-Hz flash of light (8

F 84.4 Flash visual evoked potential (fVEP) from a monkey. (See text for details.) (Recordings were made in the lab of James Burke, Allergan, Inc.)

:

939

F 84.5 Pattern visual evoked potential (pVEP) from a monkey. (See text for details.) (Recordings were made in the lab of James Burke, Allergan, Inc.)

F 84.6 Sweep visual evoked potential (sVEP) from a monkey. (See text for details.) (Recordings were made in the lab of James Burke, Allergan, Inc.)

cd s/m2) produced in a Ganzfeld. The data were acquired with an Espion system (Diagnosys LLC, Littleton, MA). The VEP recorded in response to a flash of light can be a complicated waveform consisting of several negativeand posi- tive-going waves.15 These waves have been given many different names by different investigators.38 For our purposes, the waveforms will be labeled P or N for positiveor negativegoing waveforms, respectively. To conform to the monkey fVEP literature, following the P or N will be the approximate latency of the peak of the waveform (e.g., P100 for a positive waveform with a peak latency of about 100 ms).

Several different positiveand negative-going waveforms have been identified in the fVEP.28,52,53 The largest are a negative-going wave at about 40 ms (N40), a positive-going wave at about 65 ms (P65), and a second negative-going wave at about 95 ms (N95) after the flash of light. For figure 84.4, the peaks are N44, P67, and N86. The amplitude from N44 to P67 is 25.2 mV. As flash intensity increases, the amplitude of the response increases and the latency decreases.29 The stimulus wavelength also has a significant effect on the amplitude and latency of the response.

The origin of the fVEP response was assessed by combining VEP recordings, multiunit activity response profiles, and current source density analysis in the same animals.28,52,53,104 The findings indicate that the early components of the fVEP (N40 and P65) originate in the striate cortex and later components are generated in the extrastriate cortex (e.g., possibly V4).28 Peaks recorded before N40 may arise from LGN activity104 or the optic radiations.52,105 The N40 peak may originate from EPSP (excitatory postsynaptic potential) activity of stellate cells and depolarization of thalamic axons in layer 4c of the striate cortex.105 The P65 component results from the hyperpolarization of the stellate cells in layer 4c. The human fVEP is composed of a negative-going wave at 70 ms (N70) and a positive-going wave at about 100 ms (P100) after the flash of light. Kraut et al.52 have suggested that the monkey fVEP N40 and P65 peaks correlate with the human fVEP N70 and P100 peaks, respectively. Very early components of the fVEP in humans (less than 65 ms after the flash onset) may be from the electroretinogram.5 Thus, the fVEP may be used to assess the function of specific layers of the striate cortex in monkeys and humans.

P VEP Figure 84.5 contains an example of a pattern VEP (pVEP). The stimulus was a checkerboard pattern (100% contrast) square wave modulated at 1 Hz. Each check subtended 0.5 degree of visual angle at a 1-m viewing distance. The graph is the average of 200 phase reversals. Electrode placement is the same as in the fVEP in figure 84.4. The pVEP to gratings usually consist of a positive-going wave at 60 ms (P60), a negative-going wave at about 80 ms (N80), and a second positive-going wave at about 125 ms (P125) after stimulus alternation.105 Typically, pattern stimuli consist of checkerboard patterns or gratings (sine or square wave). The size, contrast, and temporal modulation of the pattern will affect the amplitude and latency of the response.18,26,30,51,64,73,74,127 The location of the recording electrode over the striate cortex may also influence the waveform that is recorded.18 The closer the electrode is placed to the foveal projection, the higher the amplitude of the response.127 In figure 84.5, the peak waveform latencies are P33, N46, P68, N78, and P105. The amplitude from N78 to P105 is 10.4 mV.

940

The origin of the pVEP has also been investigated.18,105,127 These investigations utilized pVEP recordings, multiunit activity response profiles, and current source density analysis. In addition to the peaks listed above for the pVEP, Schroeder et al.105 have identified an earlier set of peaks (P40 and N50) in some animals. Their findings indicate that the N50 results from activation of stellate cells in layer 4c of the striate cortex. The P60 arises from the activation of supragranular (i.e., layers 2 and 3 of the striate cortex) neurons, possibly pyramidal cells. Later waves appear to arise from multiple generators that may include extrastriate regions. Schroeder et al.105 suggest that the N50, P60, and N80 peaks of the monkey pVEP are equivalent to the N70, P100, and post-P100 negativity in the human pVEP.

The pVEP was used to assess conditions that may affect the spatial or temporal processing of the visual pathway.26,49,64 Marx et al.64 found that in monkeys with glaucoma, the pVEP was reduced in amplitude to low-spatial- frequency stimuli. Johnson et al.49 found reductions in the pVEP amplitude in glaucoma monkeys, but there was not a spatial frequency effect. These differences might be the result of the different methodologies employed. Marx et al.64 used a square wave grating, while Johnson et al.49 used a checkerboard pattern. Additionally, the temporal and spatial frequencies presented were different. Spatial-frequency- dependent changes in the pVEP have also been observed in a Parkinsonian-induced syndrome in monkeys.26

Amblyopia is a common visual condition that was investigated with the pVEP.123,133 These investigations indicated that strabismic amblyopic monkeys and humans have similar abnormalities of the visual pathway. Normal visual processes such as color vision54,55 and texture segregation57 were also investigated with the pVEP. Thus, the pVEP can be used to assess normal visual processes (i.e., spatial, temporal, contrast, and color mechanisms), as well as conditions that alter visual processing (e.g., glaucoma, amblyopia, and Parkinson’s disease).

A modification of the pattern VEP is the sweep VEP (sVEP). The sVEP technique was developed to rapidly obtain visual acuity estimates in humans.77,78,125 This technique utilizes sine wave or square wave gratings. Several different spatial frequencies, centered on the subject’s visual acuity, are presented in rapid succession, and the individual responses are partitioned out on the basis of the stimulus spatial frequency. A plot of spatial frequency versus response amplitude is then obtained. Visual acuity can then be determined from this plot. This technique can be used to estimate visual acuity much more quickly than a pVEP technique. The sVEP can also be used to determine thresholds for other visual parameters (e.g., contrast and temporal frequency).

Figure 84.6 shows the sVEP results for one monkey (Macaca fasicularis). The electrode placement is the same as

in figures 84.4 and 84.5. The sVEP technique was described by Norcia et al.76 The horizontal axis displays spatial frequency, and the vertical axis displays the amplitude of the response. The solid symbols display the Fourier amplitude at twice the fundamental frequency (15 Hz), and the open symbols display the noise (15.97 Hz). The phase lag of the response increased slightly as the spatial frequency was increased until the response fell to noise (not shown). At higher spatial frequencies, the change in phase was random. Norcia and Tyler77 determined acuity by fitting a line to the high-spatial-frequency limb of the function and extrapolating this to 0 mV. The extrapolated acuity for this animal was 9.3 cpd, or about 20/65.

The sVEP was used in monkeys to measure visual acuity.10,30,56,104,129,138 The monkey sVEP acuity is typically between 15 and 30 cpd.30,129,138 Squirrel monkeys (Saimiri sciureus) have lower visual acuities than macaque monkeys (Macaca mulatta).138 The visual acuity obtained with the sVEP is similar to that obtained with the steady-state VEP and by psychophysical methods.3,19,30,41,50,70,71 Furthermore, the sVEP acuity is similar with or without propofol anesthesia.3 The sVEP was also used to examine acuity in monkey models of amblyopia,10,56,138 as well as to examine short-term fluctuations in acuity after laser exposure.104

The mouse visual evoked potential

F VEP The fVEP has been examined in mice to determine the effects of various drugs on the cortex,1,2,42,121 examine the effects of albinism or aging on the visual pathway,1,42,43 determine the absolute light sensitivity,35 and examine ultradian rhythms.67 Recent studies have examined the effect of various stimulus parameters on the flash VEP response.61,114

A typical fVEP response recorded from a light-adapted mouse is displayed in figure 84.7. The effect of a series of flash intensities is shown. The animal was anesthetized with a mixture of ketamine and xylazine (15 mg/g body weight and 7 mg/g body weight, respectively) injected intraperitoneally. The active electrode was a stainless steel bolt implanted 3 mm lateral to the lambda. The tip of the bolt rested on the dura. The reference electrode was a gold wire placed against the roof of the mouth, and the ground was a needle under the skin near the tail. The mouse was placed in a stereotaxic apparatus (Stoelting, Wood Dale, IL) that held the snout. The stereotaxic apparatus was placed in a Ganzfeld, and the stimulus was produced by a photostimulator set at a temporal frequency of 1 Hz. Each waveform is the average of 100 repetitions. In agreement with previous publications on fVEPs, the initial positive-going wave is referred to as P1, and the subsequent negative-gong wave is N1. The second large positive waveform is P2.42,43,121 The

:

941

F 84.7 Flash visual evoked potential from a mouse. (See text for details.)

latency of the P1, N1, and P2 peaks and the amplitude of the response are typically determined. In this example, the latencies of the P1, N1, and P2 waves for the top response are approximately 54, 75, and 96 ms, respectively. The amplitude from N1 to P2 is 82 mV. As the stimulus intensity decreases, the amplitude of the response decreases and the latency increases (i.e., similar to monkey results).

Early studies of the fVEP in mice examined the extent of the visual cortex136 or the effects of anesthetics.2,42 Later studies of the fVEP have examined the effect of stimulus parameters such as temporal frequency1,114 and flash intensity.35 These studies demonstrated that certain anesthetics (e.g., pentobarbitol, chlorprothixene, and haloperidol) could alter the latency of the VEP response. Increasing the temporal frequency of the stimulus resulted in an increase in the latency of the response and a decrease in the amplitude. The most recent studies have used the fVEP to examine the effects of specific genetic mutations in mice.59,85,97

In conclusion, early studies of the fVEP in mice have demonstrated the basic waveform. Recently, the fVEP has been used to assess physiological functions of the mouse visual pathway. Future studies are needed to assess the effects of various stimulus attributes (e.g., background and stimulus intensity, wavelength, and temporal frequency) so that a complete picture of the fVEP response can be obtained. Additionally, studies should be carried out to determine the optimal recording technique (e.g., electrode locations and anesthesia) for the mouse fVEP. The electrode configuration and the anesthetic employed have a significant effect on the shape and timing of the VEP waveform. These studies will be necessary before the fVEP can be used to routinely assess the mouse visual pathway and comparisons between labs can be made.

F 84.8 Pattern visual evoked potential from a mouse. (See text for details.)

P VEP The pVEP can be used to assess several aspects of the visual system. The field size, pattern size, contrast, retinal location, and rate of stimulus presentation all affect the response. Thus, with the pVEP, the visual acuity, contrast sensitivity, and motion sensitivity can be deter- mined.89–91,114 There is a good correlation between these parameters that are determined psychophysically and electrophysiologically.27,95,109

The waveform for the pVEP has a simpler morphology than the fVEP. A typical pVEP recorded from a mouse is displayed in figure 84.8. The electrode positions are the same as those for the fVEP in figure 84.7. The stimulus is a checkerboard pattern reversing (square wave) at a temporal frequency of 4 Hz. Each check subtended an angle of 6.2 degrees at the mouse eye. The pVEP consists of a negativegoing wave at about 30 ms and a positive-going wave at about 60 ms. The amplitude from the first negative-going wave to the positive-going wave is 3.1 mV.

Several different pattern stimuli have been used to assess the mouse visual system.89,90,114 Porciatti et al.89 assessed the visual acuity, cortical magnification factor (M ), ocularity, contrast threshold, temporal tuning function, motion sensitivity, and luminance effect with the pVEP. Their stimuli were horizontal sine wave gratings of different spatial frequencies that covered 81 ¥ 86 degrees of the visual field. The mice were anesthetized with 20% urethane (Sigma, 8 ml/kg) and mounted in a stereotaxic apparatus. A craniotomy was made over the visual cortex, and the dura was left intact. The electrode (a resin-coated microelectrode) was placed approximately 3 mm lateral to the lambda (the intersection between the saggital and lambdoid sutures) overlying the binocular area of the striate visual cortex.21

942

F 84.9 Sweep visual evoked potential from a mouse. (See text for details.)

The acuity obtained with the pVEP was similar to previous psychophysical measures of acuity in the mouse. Peak responses were obtained with stimuli of 0.06–0.1 c/deg. The acuity was determined by extrapolation of the high-spatial- frequency data to the x-axis or zero amplitude. Porciatti et al.89 found an average acuity of 0.6 c/deg with the pVEP. Studies of optokinetic nystagmus have suggested that the acuity of mice is about 0.5 c/deg.109 Forced choice, psychophysical techniques have also resulted in acuity estimates of 0.5–0.6 c/deg.27,95 Thus, the acuity of mice is slightly more than 1 log unit less than that of primates.

Sweep VEP acuity estimates are similar to those obtained using psychophysical methods.98 Figure 84.9 displays an sVEP response for a mouse. The electrode position and anesthesia are the same as previously described. Spatial frequency is plotted on the horizontal axis, and the response amplitude (the second harmonic of the discrete Fourier transform, 8 Hz) is plotted on the vertical axis (solid symbols). The open symbols represent the noise (10 Hz). The stimulus was a horizontally oriented sine wave grating. The stimulus contrast was 80%, and the temporal reversal rate (square wave) was 4 Hz. The screen luminance was 100 cd/m2, and the screen subtended 100 degrees (H) by 82 degrees (V) at the mouse eye. Stimulus production and data collection were carried out with the Enfant (Neuroscientific Corp.) system.

The data in the figure display two peaks in the sVEP function: one peak at 0.24 cpd and a second peak at 0.50 cpd. This double-peaked function has been observed in human sVEP data.34,77,116,117 In humans, it has been postulated that the double peak results from the interaction of two parallel channels (i.e., the proposed transient and sustained or M and P channels) of information flow reaching the cortex at different times. Thus, at intermediate spatial frequencies (0.3–0.4 cpd in this mouse), these two parallel channels may

interact destructively to produce a decrease in the response amplitude. Acuity can be determined by fitting a line to the high-spatial-frequency data and extrapolating this line to the noise. The horizontal dashed line depicts the average noise for the data set. By using this technique for this set of data (the dotted line in the figure), the acuity was estimated to be 0.84 cpd. This corresponds to an acuity of 20/714. This is similar to previous reports of acuity measured with the pVEP and using psychophysical techniques.

Contrast sensitivity has not been measured psychophysically in the mouse; however, pVEP data suggest that the peak contrast threshold is about 5%.89 This is similar to the peak contrast threshold of the rat.8 Temporal tuning functions for the mouse striate cortex determined from pVEPs suggest that there is a peak at 2–4 Hz.89,114 On either side of this, the sensitivity is less. The temporal frequency cutoff is about 12 Hz. The peak of the temporal tuning function correlates with a stimulus velocity of about 67 deg/s. The temporal frequency cutoff correlates with a stimulus velocity of about 200 deg/s. These values agree well with the optimal stimulus velocities for the cortical cells in mice.21 Drager21 found that mouse cortical cells preferred stimulus velocities from 5 to 200 deg/s with some cells as high as 1000 deg/s. She speculated that this was the result of the anatomy of the mouse eye. The relationship between the mouse lens and the eye’s axial length would result in a minimized image of the world on the retina. Thus, only rapidly moving objects would optimally stimulate retinal cells.

Porciatti et al.89 also examined the effect of mean luminance on the amplitude of the pVEP. Over the range of 0.25 cd/m2 to 25 cd/m2, the VEP amplitude increased with the maximum amplitude obtained at the highest luminance. These luminance levels are in the mesopic and photopic ranges. Since the VEP amplitude is greatest at the highest luminance, the mouse VEP may be cone-driven.

By driving an electrode to various layers of the cortex and monitoring the pVEP, the source of the VEP can be determined. On either side of the source, the VEPs will have opposite polarities. Porciatti et al.,89 using this technique in the mouse, determined that the source of the pVEP is in the supragranular layers of area V1. This agrees with work on the rat25,87 and monkey.105

In conclusion, the pVEP has been used to assess several aspects of the mouse visual system. The pVEP results correspond to the psychophysical findings for the mouse and can be used to make these measurements more efficiently. Thus, the pVEP can be used to assess the visual pathway in mouse models of various visual system diseases.

General conclusions

International standards for VEP recordings in humans have recently been accepted.39 Other standards for animals (e.g.,

:

943

electroretinograms in dogs) have also been proposed.75 These standards were the result of many investigations into stimulus parameters and recording techniques and their effect on the specific electrophysiological test. The standards allow for predictable results based on a specific recording technique and stimulus. The groundwork for VEP recording in mice and monkeys has been done. It is clear that VEPs can be readily recorded from the central visual field of mice and monkeys. The fVEP can be employed to determine whether there are any lesions of the visual pathway from the retina to the striate cortex. Pattern VEPs can be employed to assess several aspects of the visual system (e.g., visual acuity, cortical magnification factor (M ), ocularity, contrast threshold, temporal tuning function, motion sensitivity, and luminance effects). Multifocal VEPs, which have not been reported in mice or monkeys, may prove beneficial in assessing specific aspects of the visual field. Future studies are needed to extend this work so that the effect of various stimulus parameters on the VEP is clarified. These studies may allow for standards to be developed for mice and monkeys so that the visual effect of alterations in the visual system due to disease or experimental manipulation can be readily identified.

REFERENCES

1.Adachi-Usami E: Senescence of visual function as studied by visually evoked cortical potentials. Jpn J Ophthalmol 1990; 34:81–94.

2.Adachi-Usami E, Ikeda H, Satoh H: Haloperidol delays visually evoked cortical potentials but not electroretinograms in mice. J Ocul Pharmacol Ther 1990; 6(3):203–210.

3.Aiyer A, Wilson JR, Swenson B, Levi A, Boothe RG: Acuity assessment by behavioral and VEP methods: A comparison in monkeys [ARVO Abstract]. Invest Ophthalmol Vis Sci 1996; 37:S708.

4.Akabane A, Saito K, Suzuki Y, Shibuya M, Sugita K: Monitoring visual evoked potentials during retraction of the canine optic nerve: Protective effect of unroofing the optic canal. J Neurosurg 1995; 82(2):284–287.

5.Allison T, Matsumya Y, Goff GD, Goff WR: The scalp topography of human visual evoked potentials. Electroencephalogr Clin Neurophysiol 1977; 42:185–197.

6.Baitch LW, Ridder WH III, Harwerth RS, Smith EL III: Binocular beat VEPs: Losses of cortical binocularity in monkeys reared with abnormal visual experience. Invest Ophthalmol Vis Sci 1991; 32(12):3096–3103.

7.Balkema GW, Drager UC: Origins of uncrossed retinofugal projections in normal and hypopigmented mice. Vis Neurosci 1990; 4(6):595–604.

8.Birch D, Jacobs GH: Spatial contrast sensitivity in albino and pigmented rats. Vision Res 1979; 19:933–937.

9.Biro K, Palhalmi J, Toth AJ, Kukorelli T, Juhasz G: Bimoclomol improves early electrophysiological signs of retinopathy in diabetic rats. Neuroreport 1998; 9(9):2029–2033.

10.Boothe RG, Louden T, Aiyer A, Izquierdo A, Drews C, Lambert SR: Visual outcome after contact lens and intra-

ocular lens correction of neonatal monocular aphakia in monkeys. Invest Ophthalmol Vis Sci 2000; 41(1):110–119.

11.Boysen ST, Berntson GG: Visual evoked potentials in the great apes. Electroencephalogr Clin Neurophysiol 1985; 62(2): 150–153.

12.Bullock TH, Hofmann MH, New JG, Nahm FK: Dynamic properties of visual evoked potentials in the tectum of cartilaginous and bony fishes, with neuroethological implications. J Exp Zool Suppl 1990; 5:142–155.

13.Callaway EM: Local circuits in primary visual cortex of the macaque monkey. Ann Rev Neurosci 1998; 21:47–74.

14.Carter-Dawson LD, LaVail MM: Rods and cones in the mouse retina: I. Structural analysis using light and electron microscopy. J Comp Neurol 1979; 188(2):245–262.

15.Ciganek ML: The EEG response (evoked potential) to light stimulus in man. Electroencephalogr Clin Neurophysiol 1961; 13:165–172.

16.Coupland SG, Cochrane DD: Maturational topography of the visual evoked potential in fetal lambs. Doc Ophthalmol 1987; 66(4):337–346.

17.Cowey A, Rolls ET: Human cortical magnification factor and its relation to visual acuity. Exp Brain Res 1974; 21(5):447–454.

18.Dagnelie G, Spekreijse H, van Dijk B: Topography and homogeneity of monkey V1 studied through subdurally recorded pattern-evoked potentials. Vis Neurosci 1989; 3(6):509–525.

19.De Valois RL, Morgan H, Snodderly DM: Psychophysical studies of monkey vision: III. Spatial luminance contrast sensitivity tests of macaque and human observers. Vision Res 1974; 14(1):75–81.

20.Dow BM, Snyder AZ, Vautin RG, Bauer R: Magnification factor and receptive field size in foveal striate cortex of the monkey. Exp Brain Res 1981; 44(2):213–228.

21.Drager UC: Receptive fields of single cells and topography in mouse visual cortex. J Comp Neurol 1975; 160(3):269–290.

22.Drager UC: Observations on monocular deprivation in mice. J Neurophysiol 1978; 41(1):28–42.

23.Drager UC, Olsen JF: Origins of crossed and uncrossed retinal projections in pigmented and albino mice. J Comp Neurol 1980; 191(3):383–412.

24.Drasdo N: The neural representation of visual space. Nature 1977; 266(5602):554–556.

25.Fontanesi G, Siciliano R, Porciatti V, Bagnoli P: Somastatin depletion modifies the functional activity of the visual cortex in the rat. Vis Neurosci 1996; 3:327–334.

26.Ghilardi MF, Bodis-Wollner I, Onofrj MC, Marx MS, Glover

AA:Spatial frequency-dependent abnormalities of the

pattern electroretinogram and visual

evoked potentials

in a parkinsonian monkey model. Brain

1988; 111(1):131–

149.

 

27.Gianfranceschi L, Fiorentini A, Maffei L: Behavioural visual acuity of wild type and bc12 transgenic mouse. Vision Res 1999; 39(3):569–574.

28.Givre SJ, Schroeder CE, Arezzo JC: Contribution of extrastriate area V4 to the surface-recorded flash VEP in the awake macaque. Vision Res 1994; 34(4):415–428.

29.Givre SJ, Arezzo JC, Schroeder CE: Effects of wavelength on the timing and laminar distribution of illuminanceevoked activity in macaque V1. Vis Neurosci 1995; 12(2):229– 239.

30.Glickman RD, Rhodes JW, Coffey DJ: Noninvasive techniques for assessing the effect of environmental stressors on visual function. Neurosci Biobehav Rev 1991; 15(1):173–181.

944

31.Godement P, Salaun J, Imbert M: Prenatal and postnatal development of retinogeniculate and retinocollicular projections in the mouse. J Comp Neurol 1984; 230:552–575.

32.Gordon JA, Stryker MP: Experience-dependent plasticity of binocular responses in the primary visual cortex of the mouse. J Neurosci 1996; 16(10):3274–3286.

33.Goto Y, Furuta A, Tobimatsu S: Magnesium deficiency differentially affects the retina and visual cortex of intact rats. J Nutr 2001; 131(9):2378–2381.

34.Gottlob I, Wizov SS, Odom JV, Reinecke RD: Predicting optotype visual acuity by swept spatial visual-evoked potentials. Clin Vision Sci 1993; 8:417–423.

35.Green DG, Herreros de Tejada P, Glover MJ: Electrophysiological estimates of visual sensitivity in albino and pigmented mice. Vis Neurosci 1994; 11(5):919–925.

36.Guire ES, Lickey ME, Gordon B: Critical period for the monocular deprivation effect in rats: Assessment with sweep visually evoked potentials. J Neurophysiol 1999; 81(1):121–128.

37.Gyllensten L, Malmfors T, Norrlin-Grettve ML: Developmental and functional alterations in the fiber composition of the optic nerve in visually deprived mice. J Comp Neurol 1966; 128:413–418.

38.Harding GFA: History of visual evoked cortical testing. In Arden GB (ed): Principles and Practice of Clinical Electrophysiology of Vision. St. Louis, Mosby, 1991, pp 17–22.

39.Harding GFA, Odom JV, Spileers W, Spekreijse H: Standard for visual evoked potentials. Vision Res 1996; 36:3567–3572.

40.Hart WM: Adler’s Physiology of the Eye. St. Louis, Mosby, 1992.

41.Harwerth RS, Smith EL III, Boltz RL, Crawford ML, von Noorden GK: Behavioral studies on the effect of abnormal early visual experience in monkeys: Spatial modulation sensitivity. Vision Res 1983; 23(12):1501–1510.

42.Henry KR, Rhoades RW: Relation of albinism and drugs to the visual evoked potential of the mouse. J Comp Physiol Psychol 1978; 92(2):271–279.

43.Henry KR, Rhoades RW, Haythorn MM: Effects of ambient lighting and the albino gene on the developing visual evoked potential of the mouse. Physiol Psychol 1977; 5:204–208.

44.Herreros de Tejada P, Munoz Tedo C, Costi C: Behavioral estimates of absolute visual threshold in mice. Vision Res 1997; 37(17):2427–2432.

45.Hubel DH, Wiesel TN: Receptive fields, binocular interaction and functional architecture in the cat’s visual cortex. J Physiol 1962; 160:106–154.

46.Hubel DH, Wiesel TN: Receptive fields and functional architecture of monkey striate cortex. J Physiol 1968; 195(1):215–243.

47.Hubel DH, Wiesel TN: Ferrier lecture: Functional architecture of macaque monkey visual cortex. Proc R Soc Lond B Biol Sci 1977; 198(1130):1–59.

48.Jacobs GH, Neitz J, Deegan JF II: Retinal receptors in rodents maximally sensitive to ultraviolet light. Nature 1991; 353(6345):655–656.

49.Johnson MA, Drum BA, Quigley HA, Sanchez RM, Dunkelberger GR: Pattern-evoked potentials and optic nerve fiber loss in monocular laser-induced glaucoma. Invest Ophthalmol Vis Sci 1989; 30(5):897–907.

50.Kiorpes L, Kiper DC: Development of contrast sensitivity across the visual field in macaque monkeys (Macaca nemestrina). Vision Res 1996; 36(2):239–247.

51.Klemm WR, Goodson RA, Allen RG: Steady-state visual evoked responses in anesthetized monkeys. Brain Res Bull 1984; 13(2):287–291.

52.Kraut MA, Arezzo JC, Vaughan HG Jr: Intracortical generators of the flash VEP in monkeys. Electroencephalogr Clin Neurophysiol 1985; 62(4):300–312.

53.Kraut MA, Arezzo JC, Vaughan HG Jr: Inhibitory processes in the flash evoked potential of the monkey. Electroencephalogr Clin Neurophysiol 1990; 76(5):440–452.

54.Kulikowski JJ, Robson AG, Murray IJ: Scalp VEPs and intracortical responses to chromatic and achromatic stimuli in primates. Doc Ophthalmol 2002; 105:243–279.

55.Kulikowski JJ, Walsh V, McKeefry D, Butler SR, Carden D: The electrophysiological basis of colour processing in macaques with V4 lesions. Behav Brain Res 1994; 60(1):73–78.

56.Lambert SR, Aiyer A, Grossniklaus H: Infantile lensectomy and intraocular lens implantation with long-term follow-up in a monkey model. J Pediatr Ophthalmol Strabismus 1999; 36(5):271–278.

57.Lamme VA, Van Dijk BW, Spekreijse H: Texture segregation is processed by primary visual cortex in man and monkey: Evidence from VEP experiments. Vision Res 1992; 32(5): 797–807.

58.LaVail JH, Nixon RA, Sidman RL: Genetic control of retinal ganglion cell projections. J Comp Neurol 1978; 182(3):399–421.

59.Lehman DM, Harrison JM: Flash visual evoked potentials in the hypomyelinated mutant mouse shiverer. Doc Ophthalmol 2002; 104(1):83–95.

60.Lilienthal H, Lenaerts C, Winneke G, Hennekes R: Alteration of the visual evoked potential and the electroretinogram in lead-treated monkeys. Neurotoxicol Teratol 1988; 10(5):417–422.

61.Lopez L, Brusa A, Fadda A, Loizzo S, Martinangeli A, Sannita WG, et al: Modulation of flash stimulation intensity and frequency: Effects on visual evoked potentials and oscillatory potentials recorded in awake, freely moving mice. Behav Brain Res 2002; 131(1–2):105–114.

62.Lund JS: Anatomical organization of macaque monkey striate visual cortex. Ann Rev Neurosci 1988; 11:253–288.

63.Mangini NJ, Pearlman AL: Laminar distribution of receptive field properties in the primary visual cortex of the mouse. J Comp Neurol 1980; 193(1):203–222.

64.Marx MS, Podos SM, Bodis-Wollner I, Lee PY, Wang RF, Severin C: Signs of early damage in glaucomatous monkey eyes: Low spatial frequency losses in the pattern ERG and VEP. Exp Eye Res 1988; 46(2):173–184.

65.Mason C, Kandel ER: Central visual pathways. In Jessell TM (ed): Principles of Neural Science, ed 3. Norwalk, CT Appleton & Lange, 1991, pp 420–439.

66.Matsuzaki M, Dowling KC: Effects of phencyclidine (PCP) on the visual evoked potentials in the rhesus monkey. Brain Res Bull 1983; 10(1):33–38.

67.Mazzucchelli A, Conte S, D’Olimpio F, Ferlazzo F, Loizzo A, Palazzesi S, et al: Ultradian rhythms in the N1-P2 amplitude of the visual evoked potential in two inbred strains of mice: DBA/2J and C57BL/6. Behav Brain Res 1995; 67(1):81– 84.

68.Meeren HK, Van Luijtelaar EL, Coenen AM: Cortical and thalamic visual evoked potentials during sleep-wake states and spike-wave discharges in the rat. Electroencephalogr Clin Neurophysiol 1998; 108(3):306–319.

69.Menner E: Untersuchunger uber die Retina mit besonderer Berucksichtigung der ausseren Kornerschichte. Z Vergl Physiol 1928; 8:761–826.

70.Merigan WH, Katz LM: Spatial resolution across the macaque retina. Vision Res 1990; 30(7):985–991.

:

945

71.Merigan WH, Pasternak T, Zehl D: Spatial and temporal vision of macaques after central retinal lesions. Invest Ophthalmol Vis Sci 1981; 21(1, Pt 1):17–26.

72.Mutti DO, Ver Hoeve JN, Zadnik K, Murphy CJ: The artifact of retinoscopy revisited: Comparison of refractive error measured by retinoscopy and visual evoked potential in the rat. Optom Vis Sci 1997; 74(7):483–484.

73.Nakayama K, Mackeben M, Sutter E: Narrow spatial and temporal frequency tuning in the alert monkey VEP. Brain Res 1980; 193(1):263–267.

74.Nakayama K, Mackeben M: Steady state visual evoked potentials in the alert primate. Vision Res 1982; 22(10): 1261–1271.

75.Narfström K, Ekesten B, Rosolen SG, Spiess BM, Percicot CL, Ofri R: Guidelines for clinical electroretinography in the dog. Doc Ophthalmol 2002; 105:83–92.

76.Norcia AM, Clarke M, Tyler CW: Digital filtering and robust regression techniques for estimating sensory thresholds from the evoked potential. IEEE Eng Med Biol 1985; 4:26–32.

77.Norcia AM, Tyler CW: Infant VEP acuity measurements: Analysis of individual differences and measurement error.

Electroencephalogr Clin Neurophysiol 1985; 61(5):359–369.

78.Norcia AM, Tyler CW: Spatial frequency sweep VEP: Visual acuity during the first year of life. Vision Res 1985; 25(10):1399–1408.

79.Northmore DP, Granda AM: Refractive state, contrast sensitivity, and resolution in the freshwater turtle, Pseudemys scripta elegans, determined by tectal visual-evoked potentials. Vis Neurosci 1991; 7(6):619–625.

80.Ochikubo F, Nagata T, Yoshikawa Y, Matsubara Y, Kai C, Yamanouchi Y: Electroencephalogram and evoked potentials in the primate model of viral encephalitis. Electroencephalogr Clin Neurophysiol 1993; 88(5):397–407.

81.Oku H, Sugiyama T, Kojima S, Watanabe T, Ikeda T: Improving effects of topical administration of iganidipine, a new calcium channel blocker, on the impaired visual evoked potential after endothelin-1 injection into the vitreous body of rabbits. Curr Eye Res 2000; 20(2):101–108.

82.Okuno T, Oku H, Sugiyama T, Yang Y, Ikeda T: Evidence that nitric oxide is involved in autoregulation in optic nerve head of rabbits. Invest Ophthalmol Vis Sci 2002; 43(3):784–789.

83.O’Kusky J, Colonnier M: A laminar analysis of the number of neurons, glia, and synapses in the visual cortex (area 17) of adult macaque monkeys. J Comp Neurol 1982; 210: 278–290.

84.Padnick LB, Linsenmeier RA: Properties of the flash visual evoked potential recorded in the cat primary visual cortex. Vision Res 1999; 39(17):2833–2840.

85.Peachey NS, Roveri L, Messing A, McCall MA: Functional consequences of oncogene-induced horizontal cell degeneration in the retinas of transgenic mice. Vis Neurosci 1997; 14(4):627–632.

86.Perez-Cobo JC, Lopez de Armentia M, Sanchez-Suero S, Perez-Arroyo M: Visual evoked potentials in response to pattern reversal in the cat cortex. Rev Esp Fisiol 1994; 50(4):205–210.

87.Pizzorusso T, Fagiolini M, Porciatti V, Maffei L: Temporal aspects of contrast visual evoked potentials in the pigmented rat: Changes with dark rearing. Vision Res 1996; 37:389– 395.

88.Porciatti V, Fontanesi G, Raffaelli A, Bagnoli P: Binocularity in the little owl, Athene noctua: II. Properties of visually evoked potentials from the Wulst in response to monocular

and binocular stimulation with sine wave gratings. Brain Behav Evol 1990; 35(1):40–48.

89.Porciatti V, Pizzorusso T, Maffei L: The visual physiology of the wild type mouse determined with pattern VEPs. Vision Res 1999; 39(18):3071–3781.

90.Porciatti V, Pizzorusso T, Maffei L: Vision in mice with neuronal redundancy due to inhibition of developmental cell death. Vis Neurosci 1999; 16(4):721–726.

91.Porciatti V, Pizzorusso T, Maffei L: Electrophysiology of the postreceptoral visual pathway in mice. Doc Ophthalmol 2002; 104(1):69–82.

92.Previc FH, Allen RG, Blankenstein MF: Visual evoked potential correlates of laser flashblindness in rhesus monkeys: II. Doubled-neodymium laser flashes. Am J Optom Physiol Opt 1985; 62(9):626–632.

93.Previc FH, Blankenstein MF, Garcia PV, Allen RG: Visual evoked potential correlates of laser flashblindness in rhesus monkeys: I. Argon laser flashes. Am J Optom Physiol Opt 1985; 62(5):309–321.

94.Prospero-Garcia O, Huitron-Resendiz S, Casalman SC, Sanchez-Alavez M, Diaz-Ruiz O, Navarro L, et al: Feline immunodeficiency virus envelope protein (FIVgp120) causes electrophysiological alterations in rats. Brain Res 1999; 836(1–2):203–209.

95.Prusky GT, West PW, Douglas RM: Behavioral assessment of visual acuity in mice and rats. Vision Res 2000; 40(16):2201–2209.

96.Raymond LA, Wallace D, Raghavan R, Marcario JK, Johnson JK, Foresman LL, et al: Sensory evoked potentials in SIV-infected monkeys with rapidly and slowly progressing disease. AIDS Res Hum Retroviruses 2000; 16(12):1163– 1173.

97.Ren JC, LaVail MM, Peachey NS: Retinal degeneration in the nervous mutant mouse: III. Electrophysiological studies of the visual pathway. Exp Eye Res 2000; 70(4):467–473.

98.Ridder WH III, Nusinowitz S: Sweep VEP (sVEP) acuity in mice [abstract]. Abstract 1802. 2002 Annual Meeting Abstract and Program Planner [on CD-ROM]. Association for Research in Vision and Ophthalmology, 2002.

99.Rovamo J, Virsu V: An estimation and application of the human cortical magnification factor. Exp Brain Res 1979; 37:495–510.

100.Schmeisser ET: Flicker electroretinograms and visual evoked potentials in the evaluation of laser flash effects. Am J Optom Physiol Opt 1985; 62(1):35–39.

101.Schmeisser ET: Laser flash effects on laser speckle shift visual evoked potential. Am J Optom Physiol Opt 1985; 62(10): 709–714.

102.Schmeisser ET: Laser-induced chromatic adaptation. Am J Optom Physiol Opt 1988; 65(8):644–652.

103.Schmeisser ET: Acute laser lesion effects on acuity sweep VEPs. Invest Ophthalmol Vis Sci 1992; 33(13):3546–3554.

104.Schroeder CE, Tenke CE, Givre SJ: Subcortical contributions to the surface-recorded flash-VEP in the awake macaque.

Electroencephalogr Clin Neurophysiol 1992; 84(3):219–231.

105.Schroeder CE, Tenke CE, Givre SJ, Arezzo JC, Vaughan HG Jr: Striate cortical contribution to the surface-recorded pattern-reversal VEP in the alert monkey. Vision Res 1991; 31(7–8):1143–1157.

106.Sidman RL: Histochemical studies on photoreceptor cells. Ann N Y Acad Sci 1958; 74:182–195.

107.Silva-Barrat C, Menini C: The influence of intermittent light stimulation on potentials evoked by single flashes in photo-

946

sensitive and non-photosensitive Papio papio. Electroencephalogr Clin Neurophysiol 1984; 57(5):448–461.

108.Simmons PA, Pearlman AL: Retinotopic organization of the striate cortex (area 17) in the reeler mutant mouse. Brain Res 1982; 256(1):124–126.

109.Sinex DG, Burdette LJ, Pearlman AL: A psychophysical investigation of spatial vision in the normal and reeler mutant mouse. Vision Res 1979; 19(8):853–857.

110.Smith RS, John SWM, Nishina PM: The posterior segment and orbit. In Smith RS (ed): Systematic Evaluation of the Mouse Eye: Anatomy, Pathology, and Biomethods. Boca Raton, FL, CRC Press, 2002, pp 25–44.

111.Strain GM, Claxton MS, Prescott-Mathews JS, LaPhand DJ: Electroretinogram and visual-evoked potential measurements in sheep. Can J Vet Res 1991; 55(1):1–4.

112.Strain GM, Graham MC, Claxton MS, Olcott BM: Postnatal development of brainstem auditory-evoked potentials, electroretinograms, and visual-evoked potentials in the calf. J Vet Intern Med 1989; 3(4):231–237.

113.Strain GM, Jackson RM, Tedford BL: Visual evoked potentials in the clinically normal dog. J Vet Intern Med 1990; 4(4):222–225.

114.Strain GM, Tedford BL: Flash and pattern reversal visual evoked potentials in C57BL/6J and B6CBAF1/J mice. Brain Res Bull 1993; 32(1):57–63.

115.Strain GM, Tedford BL, Littlefield-Chabaud MA, Trevino LT: Airand bone-conduction brainstem auditory evoked potentials and flash visual evoked potentials in cats. Am J Vet Res 1998; 59(2):135–137.

116.Strasburger H, Murray IJ, Remky A: Sustained and transient mechanisms in the steady-state visual evoked potential: Onset presentation compared to pattern reversal. Clin Vision Sci 1993; 8:211–234.

117.Strasburger H, Scheidler W, Rentschler I: Amplitude and phase characteristics of the steady-state visual evoked potential. Appl Optics 1988; 27:1069–1088.

118.Suzuki M, Sitizyo K, Takeuchi T, Saito T: Visual evoked potential from scalp in guinea pigs. J Vet Med Sci 1991; 53(2):301–305.

119.Takeuchi T, Suzuki M, Sitizyo K, Isobe R, Saito T, Umemura T, et al: Visual evoked potentials in guinea pigs with brain lesion. J Vet Med Sci 1992; 54(5):813–820.

120.Takeuchi T, Suzuki M, Sitizyo K, Saito T: Postnatal development of visual evoked potentials in Japanese black calves. Jpn J Physiol 1993; 43(6):809–815.

121.Tebano MT, Luzi M, Palazzesi S, Pomponi M, Loizzo A: Effects of cholinergic drugs on neocortical EEG and flashvisual evoked potentials in the mouse. Neuropsychobiology 1999; 40(1):47–56.

122.Tootell RB, Switkes E, Silverman MS, Hamilton SL: Functional anatomy of macaque striate cortex: II. Retinotopic organization. J Neurosci 1988; 8(5):1531–1568.

123.Tychsen L, Boothe RG: Latent fixation nystagmus and nasotemporal asymmetries of motion visually evoked potentials in naturally strabismic primate. J Pediatr Ophthalmol Strabismus 1996; 33(3):148–152.

124.Tychsen L, Burkhalter A, Boothe RG: [Functional and structural abnormalities in the visual cortex in early childhood strabismus.] Klin Monatsbl Augenheilkd 1996; 208(1):18–22.

125.Tyler CW, Apkarian P, Levi DM, Nakayama K: Rapid assessment of visual function: An electronic sweep technique for the pattern visual evoked potential. Invest Ophthalmol Vis Sci 1979; 18(7):703–713.

126.Valverde F, Esteban ME: Peristriate cortex of mouse: Location and the effects of enucleation on the number of dendritic spines. Brain Res 1968; 9(1):145–148.

127.Van der Marel EH, Dagnelie G, Spekreijse H: Subdurally recorded pattern and luminance EPs in the alert rhesus monkey. Electroencephalogr Clin Neurophysiol 1984; 57(4):354–368.

128.Van Essen DC, Lewis JW, Drury HA, Hadjikhani N, Tootell RB, Bakircioglu M, et al: Mapping visual cortex in monkeys and humans using surface-based atlases. Vision Res 2001; 41(10–11):1359–1378.

129.Ver Hoeve JN, Danilov YP, Kim CB, Spear PD: VEP and PERG acuity in anesthetized young adult rhesus monkeys. Vis Neurosci 1999; 16(4):607–617.

130.Wagor E, Mangini NJ, Pearlman AL: Retinotopic organization of striate and extrastriate visual cortex in the mouse. J Comp Neurol 1980; 193(1):187–202.

131.Wassle H, Grunert U, Rohrenbeck J, Boycott BB: Cortical magnification factor and the ganglion cell density of the primate retina. Nature 1989; 341:643–646.

132.Watanabe M, Ozaki T, Mushiroi T, Ukai Y, Ueda F, Kimura K, et al: Behavioral and electroencephalographic studies of beagles with an Eck’s fistula: Suitability as a model of hepatic encephalopathy. Pharmacol Biochem Behav 1997; 57(1–2):367–375.

133.Wilson JR, Noyd WW, Aiyer AD, Norcia AM, Mustari MJ, Boothe RG: Asymmetric responses in cortical visually evoked potentials to motion are not derived from eye movements.

Invest Ophthalmol Vis Sci 1999; 40(10):2435–2439.

134.Witzel DA, Smith EL III, Beerwinkle KR, Johnson JH: Arsanilic acid-induced blindness in swine: Electroretinographic and visually evoked responses. Am J Vet Res 1976; 37:521–524.

135.Wong-Riley M: Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res 1979; 171(1):11–28.

136.Woolsey TA: Somatosensory, auditory and visual cortical areas of the mouse. Johns Hopkins Med J 1967; 121(2):91– 112.

137.Yargicoglu P, Agar A, Edremitlioglu M, Kara C: The effects of cadmium and experimental diabetes on VEP spectral data and lipid peroxidation. Int J Neurosci 1998; 93(1–2):63–74.

138.Yildirim C, Tychsen L: Effect of infantile strabismus on visuomotor development in the squirrel monkey (Saimiri sciureus): Optokinetic nystagmus, motion VEP and spatial sweep VEP. Strabismus 1999; 7(4):211–219.

139.Yoshioka T, Levitt JB, Lund JS: Independence and merger of thalamocortical channels within macaque monkey primary visual cortex: Anatomy of interlaminar projections. Vis Neurosci 1994; 11(3):467–489.

:

947

This page intentionally left blank